Bladed electrosurgical probe

BACKGROUND OF THE INVENTION

The present invention generally relates to electrosurgical systems and methods for ablating, severing, dissecting, contracting, or otherwise modifying target tissues or organs. The invention relates more particularly to electrosurgical apparatus and methods for modifying a tissue or organ via molecular dissociation of tissue components, wherein the apparatus includes an active electrode in the form of a plasma blade or hook. The present invention further relates to electrosurgical instruments and methods for harvesting blood vessels such as the internal mammary artery, the saphenous vein, or the like, for use in coronary artery bypass graft procedures.

Conventional electrosurgical instruments and techniques are widely used in surgical procedures because they generally reduce patient bleeding and trauma associated with cutting operations, as compared with mechanical cutting and the like. Conventional electrosurgical procedures may be classified as operating in monopolar or bipolar mode. Monopolar techniques rely on external grounding of the patient, where the surgical device defines only a single electrode pole. Bipolar devices have two electrodes for the application of current between their surfaces. Conventional electrosurgical devices and procedures, however, suffer from a number of disadvantages. For example, conventional electrosurgical cutting devices typically operate by creating a voltage difference between the active electrode and the target tissue, causing an electrical arc to form across the physical gap between the electrode and the tissue. At the point of contact of the electric arcs with the tissue, rapid tissue heating occurs due to high current density between the electrode and the tissue. This high current density causes cellular fluids to rapidly vaporize into steam, thereby producing a “cutting effect” along the pathway of localized tissue heating. Thus, the tissue is parted along the pathway of evaporated cellular fluid, inducing undesirable collateral tissue damage in regions surrounding the target tissue.

Further, monopolar electrosurgical devices generally direct electric current along a defined path from the exposed or active electrode through the patient's body to the return electrode, the latter externally attached to a suitable location on the patient. This creates the potential danger that the electric current will flow through undefined paths in the patient's body, thereby increasing the risk of unwanted electrical stimulation to portions of the patient's body. In addition, since the defined path through the patient's body has a relatively high electrical impedance, large voltage differences must typically be applied between the return and active electrodes in order to generate a current suitable for ablation or cutting of the target tissue. This current, however, may inadvertently flow along body paths having less impedance than the defined electrical path, which will substantially increase the current flowing through these paths, possibly causing damage to or destroying surrounding tissue.

Bipolar electrosurgical devices have an inherent advantage over monopolar devices because the return current path does not flow through the patient. In bipolar electrosurgical devices, both the active and return electrode are typically exposed so that both electrodes may contact tissue, thereby providing a return current path from the active to the return electrode through the tissue. One drawback with this configuration, however, is that the return electrode may cause tissue desiccation or destruction at its contact point with the patient's tissue. In addition, the active and return electrodes are typically positioned close together to ensure that the return current flows directly from the active to the return electrode. The close proximity of these electrodes generates the danger that the current will short across the electrodes, possibly impairing the electrical control system and/or damaging or destroying surrounding tissue.

In addition, conventional electrosurgical methods are generally ineffective for ablating certain types of tissue, and in certain types of environments within the body. For example, loose or elastic connective tissue, such as the synovial tissue in joints, is extremely difficult (if not impossible) to remove with conventional electrosurgical instruments because the flexible tissue tends to move away from the instrument when it is brought against this tissue. Since conventional techniques rely mainly on conducting current through the tissue, they are not effective when the instrument cannot be brought adjacent to, or in contact with, the elastic tissue for a sufficient period of time to energize the electrode and conduct current through the tissue.

A prevalent form of cardiovascular disease is atherosclerosis in which the cardiovascular system leading to the heart is damaged or obstructed as a result of occluding material in the blood stream. Vascular complications produced by atherosclerosis, such as stenosis, aneurysm, rupture, or occlusion, increase the likelihood of angina, stroke, and heart attacks. In many cases, the obstruction of the blood stream leading to the heart can be treated by a coronary artery bypass graft (CABG) procedure.

In a conventional CABG procedure, the obstruction is bypassed by a vascular conduit established between an arterial blood source and the coronary artery to a location beyond the obstruction. The vascular conduit is typically a non-critical artery or vein harvested from elsewhere in the body. In a procedure known as “free bypass graft”, the saphenous vein is harvested from the patient's leg and is used as the vascular conduit. One end of the saphenous vein is anastomosed to the aorta and the other end is anastomosed to the diseased coronary artery at a location past the obstruction. In a procedure known as “in situ bypass graft”, an internal mammary artery (IMA) is used as the bypass conduit. In an in situ bypass graft procedure, the surgeon dissects a sufficient length of the artery from its connective tissue, then transects the artery and connects the transected end to the diseased coronary past the obstruction, and leaves the other end of the IMA attached to the arterial supply.

The internal mammary arteries are particularly desirable for use as in situ bypass grafts, as they are conveniently located, have diameters and blood flow volumes that are comparable to those of coronary arteries, and have superior patency rates. Use of the left or right IMA as a bypass graft first involves harvesting the IMA from the inside chest wall.

In conventional CABG procedures, access to the IMA is typically obtained either through a sternotomy or a gross thoracotomy. In the sternotomy or gross thoracotomy, the surgeon typically uses a saw or other cutting instrument to cut the sternum longitudinally to allow two opposing halves of the anterior portion of the rib cage to be spread apart. The opening into the thoracic cavity is created so that the surgeon may directly visualize the heart and thoracic cavity. However, such methods suffer from numerous drawbacks. For example, the longitudinal incision in the sternum often results in bone bleeding, which is difficult to stop. The bone bleeding can produce a high degree of trauma, a larger risk of complications, an extended hospital stay, and a painful recovery period for the patient. Once the surgeon has accessed the thoracic cavity, the conventional method of harvesting the IMA involves the use of scalpels or conventional electrosurgical devices. A number of disadvantages inherent in conventional electrosurgical devices have been set forth hereinabove.

Thus, there is a need for an electrosurgical apparatus which can be used for the precise removal or modification of tissue at a specific location, wherein a target tissue or organ can be dissected, transected, incised, contracted, and/or coagulated, with minimal, or no, collateral tissue damage. The instant invention provides such an apparatus and related methods, wherein tissue may be ablated or otherwise modified by a first region or element of a blade active electrode, and the modified tissue can be further modified by a second region or element of the blade active electrode, and wherein the quantity and quality of the tissue modification can be accurately controlled.

SUMMARY OF THE INVENTION

The present invention generally provides systems, apparatus, and methods for selectively applying electrical energy to cut, incise, ablate, or otherwise modify a tissue or organ of a patient. In one aspect, the electrosurgical systems and methods of the invention are useful for harvesting and dissecting veins and arteries of a patient, such as the saphenous vein or an IMA for use in a CABG procedure.

In one aspect, the present invention provides a method of creating an incision in a body structure. An electrosurgical probe is positioned adjacent the target tissue so that one or more active electrode(s) are brought into at least partial contact or close proximity with the target tissue. High frequency voltage is then applied between the active electrode(s) and one or more return electrode(s) and the active electrode(s) are moved, translated, reciprocated, or otherwise manipulated to cut through a portion of the tissue. In some embodiments, an electrically conductive fluid, e.g., isotonic saline or conductive gel, is delivered or applied to the target site to substantially surround the active electrode(s) with the fluid. In other embodiments, the active electrode(s) are immersed within the electrically conductive fluid. In both embodiments, the high frequency voltage may be selected to locally ablate or sever a target tissue, and/or to effect a controlled depth of hemostasis of severed blood vessels within the tissue. In another aspect, the electrosurgical systems and methods of the invention are useful for harvesting and dissecting veins and arteries of a patient, such as the saphenous vein or the IMA for use in a CABG procedure.

In one aspect, tissue is cut or otherwise modified by molecular dissociation or disintegration processes. (In contrast, in conventional electrosurgery tissue is cut by rapidly heating the tissue until cellular fluids explode, producing a cutting effect along the pathway of localized heating.) The present invention volumetrically removes the tissue along the cutting pathway in a cool ablation process that minimizes thermal damage to surrounding tissue. In these embodiments, the high frequency voltage applied to the active electrode(s) is sufficient to vaporize the electrically conductive fluid (e.g., gel or saline) between the active electrode(s) and the tissue. Within the vaporized fluid, a plasma is formed and charged particles (e.g., electrons) cause the molecular breakdown or disintegration of the tissue, perhaps to a depth of several cell layers. This molecular dissociation is accompanied by the volumetric removal of the tissue, e.g., along the incision of the tissue. This process can be precisely controlled to effect the volumetric removal of tissue as thin as 10 microns to 150 microns with minimal heating of, or damage to, surrounding or underlying tissue structures. A more complete description of this phenomenon is described in commonly assigned U.S. Pat. No. 5,683,366, the complete disclosure of which is incorporated herein by reference.

In a specific embodiment, the present invention provides a method of accessing a patient's thoracic cavity. The active electrode(s) are positioned in contact or in close proximity to a surface of the sternum. A high frequency voltage is applied between the active electrode(s) and a return electrode. The active electrodes are moved across the sternum to create an incision. In a specific configuration, the sides of the active electrode are slidingly engaged with the sternum as the incision is being made, so as to cause coagulation and hemostasis within the sternum.

In another exemplary embodiment, the present invention provides a method for harvesting the IMA from a patient. The electrosurgical probe is positioned adjacent the IMA and high frequency electrical energy is applied between one or more active electrode(s) and one or more return electrode(s). The probe is then moved so that the active electrode(s) volumetrically removes connective tissue adjacent to the IMA so that the IMA is free from connective tissue along a portion of its length. In an exemplary embodiment, the probe is positioned adjacent to the IMA, and advanced along the length of the IMA while high frequency electrical energy is applied between the active electrode(s) and a return electrode to remove or cut the connective tissue or other structures surrounding the IMA. The residual heat from the electrical energy also provides simultaneous hemostasis of severed blood vessels, which increases visualization and improves recovery time for the patient. In addition, the ability to simultaneously cut through tissue on either side of the IMA decreases the length of the procedure, which further improves patient recovery time. After a suitable length of the IMA has been dissected, it may be transected, and anastomosed to a diseased coronary artery using known methods. In some embodiments, an electrically conductive fluid (liquid, gas, or gel) is placed at the target site adjacent to the IMA so as to provide a current flow path between the return electrode and the active electrode.

Apparatus according to the present invention generally include an electrosurgical instrument, such as a probe or catheter, having a shaft with proximal and distal ends, one or more active electrode(s) at the distal end and one or more connectors coupling the active electrode(s) to a source of high frequency electrical energy. The active electrode(s) are preferably designed for cutting tissue; i.e., they typically have a distal edge or point. In one embodiment, a plurality of active electrodes are aligned with each other to form a linear electrode array for cutting a path through the tissue. In another exemplary embodiment, the active electrode(s) include a sharp distal point to facilitate the cutting of the target tissue. In one specific configuration, the active electrode is a blade having a sharp distal point and sides. As the sharp distal point incises the tissue, the sides of the blade slidingly contact the incised tissue. The electrical current flows through that portion of the tissue in the vicinity of the active electrode and/or the conductive fluid to the return electrode, such that the target tissue is first severed, and then the severed tissue is coagulated.

The apparatus can further include a fluid delivery element for delivering electrically conductive fluid to the active electrode(s) and the target site. The fluid delivery element may be located on the probe, e.g., a fluid lumen or tube, or it may be part of a separate instrument. Alternatively, an electrically conductive gel or spray, such as a saline electrolyte or other conductive gel, may be applied the target site. In this embodiment, the apparatus may not have a fluid delivery element. In both embodiments, the electrically conductive fluid preferably provides a current flow path between the active electrode(s) and one or more return electrode(s). In an exemplary embodiment, the return electrode is located on the probe and spaced a sufficient distance from the active electrode(s) to substantially avoid or minimize current shorting therebetween and to shield the return electrode from tissue at the target site.

In a specific configuration, the electrosurgical probe includes an electrically insulating electrode support member having a tissue treatment surface at the distal end of the probe. One or more active electrode(s) are coupled to, or integral with, the electrode support member such that the active electrode(s) are spaced from the return electrode. In one embodiment, the probe includes a plurality of active electrode(s) having distal edges linearly aligned with each other to form a sharp cutting path for cutting tissue. The active electrodes are preferably electrically isolated from each other, and they extend about 0.2 mm to about 10 mm distally from the tissue treatment surface of the electrode support member. In this embodiment, the probe may further include one or more lumens for delivering electrically conductive fluid to one or more openings around the tissue treatment surface of the electrode support member. In an exemplary embodiment, the lumen extends through a fluid tube exterior to the probe shaft that ends proximal to the return electrode.

In another aspect of the invention, the electrode support member comprises a plurality of wafer layers bonded together, e.g., by a glass adhesive or the like. The wafer layers each have conductive strips plated or printed thereon to form the active electrode(s) and the return electrode(s). In one embodiment, the proximal end of the wafer layers will have a number of holes extending from the conductor strips to an exposed surface of the wafer layers for connection to electrical conductor lead traces in the electrosurgical probe or handpiece. The wafer layers preferably comprise a ceramic material, such as alumina, and the electrode will preferably comprise a metallic material, such as gold, platinum, tungsten, palladium, silver or the like.

In another aspect of the invention, there is provided an electrosurgical probe having a blade-like active electrode affixed to an electrically insulating electrode support on the distal end of a shaft. In a specific configuration, the active electrode is in the form of a plasma blade comprising a substantially flat metal blade having at least one active edge and first and second blade sides. In one embodiment, the active electrode comprises a hook. The hook may include a curved portion. One or more portions of the hook may have a serrated edge. The return electrode is typically located on the shaft distal end proximal to the electrode support. In use, the active electrode and the return electrode are coupled to opposite poles of a high frequency power supply. The active edge may have a variety of shapes, and is adapted for generating high current densities thereon, and for precisely severing or ablating tissue or an organ in a highly controlled manner via molecular dissociation of tissue components. The first and second blade sides are adapted for engaging with tissue, such as tissue severed by the active edge, and for coagulating tissue engaged therewith.

The probe may be provided in various configurations, for example, according to a particular procedure to be performed. Thus, the electrode support may be arranged terminally or laterally on the probe, and the blade active electrode may be arranged terminally or laterally on the electrode support. The active electrode may be provided in various forms, such as a metal blade of unitary construction, e.g., a metal disc or portion thereof, a crosspiece supported by at least one electrode arm, or a hook. The shaft distal end may have a beveled end, a distal curve, and/or a laterally compressed region. Each of these features or elements of the probe may facilitate accessing a tissue or organ targeted for treatment or modification by the probe. In addition, the laterally compressed region may be adapted for accommodating the electrode support.

According to one aspect of the invention, there is provided a method for modifying a tissue using an electrosurgical probe having an active electrode in the form of a single blade which includes at least one active edge and first and second blade sides. The method involves positioning the probe such that the active electrode makes contact with, or is in close proximity to, a target tissue; and applying a high frequency voltage between the active and return electrodes sufficient to precisely sever or remove target tissue via molecular dissociation of tissue components adjacent to the active edge. The probe may be manipulated during the application of the high frequency voltage such that the active electrode is moved with respect to the target tissue. According to one aspect of the invention, the configuration of the active electrode (e.g., a hook shaped electrode) is adapted for severing tissue as the probe distal end is drawn or pulled towards the operator of the probe. In this manner, the extent to which the tissue is severed can be precisely controlled. Thereafter, the severed tissue may be coagulated upon engagement of the tissue against the first and second blade sides of the active electrode.

In another aspect of the invention, there is provided a method of harvesting a tissue or organ using an electrosurgical probe having an active electrode in the form of a single blade, wherein the single blade electrode includes an active edge and first and second blade sides. In situations where the tissue to be harvested is concealed by an overlying tissue, the tissue to be harvested must first be accessed by incising or removing the overlying tissue. Removal of the overlying tissue may be performed in various ways, including: 1) mechanically, e.g. using a scalpel, rongeur, surgical saw or drill, etc. or a combination thereof; 2) via conventional electrosurgery, e.g., a Bovie; or 3) using an electrosurgical probe of the instant invention adapted for severing tissue in a cool ablation process. Once the tissue or organ to be harvested is accessible, the tissue or organ to be harvested may be dissected by juxtaposing the active edge of the active electrode against the surrounding connective tissue, and applying a high frequency voltage between the active and return electrodes sufficient to cause molecular dissociation of connective tissue components. In this way, the connective tissue adjacent to the active electrode is ablated at a temperature in the range of 40° C. to 70° C., with no, or minimal, thermal damage to the tissue to be harvested.

The electrosurgical probe of the invention is also applicable to a broad range of other procedures, including without limitation: cutting, resection, ablation, and/or hemostasis of tissues and organs such as prostate tissue, scar tissue, myocardial tissue, and tissues of the knee, shoulder, hip, and other joints; procedures of the head and neck, such as of the ear, mouth, throat, pharynx, larynx, esophagus, nasal cavity, and sinuses; as well as procedures involving skin tissue removal and/or collagen shrinkage in the epidermis or dermis. A more detailed account of various treatments and procedures which may be carried out according to the invention is set forth in enabling detail hereinbelow.

For a further understanding of the nature and advantages of the invention, reference should be made to the following description taken in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1

is a perspective view of an electrosurgical system incorporating a power supply and an electrosurgical probe for tissue ablation, resection, incision, contraction, vessel harvesting, and hemostasis, according to the present invention;

FIG. 2

is a side view of an electrosurgical probe according to the present invention;

FIG. 3

is an end view of the distal portion of the probe of

FIG. 2

;

FIG. 4

is a cross sectional view of the distal portion of the electrosurgical probe of

FIG. 2

;

FIG. 5

is an exploded view of a proximal portion of the electrosurgical probe;

FIG. 6

is an end view of an exemplary electrode support comprising a multi-layer wafer with plated conductors for electrodes;

FIGS. 7 and 8

are side views of the electrode support of

FIG. 7

;

FIGS. 9A-13

are side views of the individual wafer layers of the electrode support;

FIGS. 9B-12B

are cross-sectional views of the individual wafer layers;

FIGS. 14 and 15

illustrate an alternative multi-layer wafer design according to the present invention;

FIG. 16

is a perspective view of an electrosurgical probe having an elongated, blade-like active electrode;

FIGS. 17A-17C

are cross-sectional views of the distal portions of three different embodiments of an electrosurgical probe according to the present invention;

FIG. 18

illustrates an electrosurgical probe with a

900

distal bend and a lateral fluid lumen;

FIG. 19

illustrates an electrosurgical system with a separate fluid delivery instrument according to the present invention;

FIGS. 20A and 20B

are cross-sectional and end views, respectively, of yet another electrosurgical probe incorporating flattened active electrodes;

FIG. 21

is a detailed end view of an electrosurgical probe having an elongate, linear array of active electrodes suitable for use in surgical cutting;

FIG. 22

is a detailed view of a single active electrode having a flattened end at its distal tip;

FIG. 23

is a detailed view of a single active electrode having a pointed end at its distal tip;

FIG. 24

is a perspective view of the distal portion of another electrosurgical probe according to the present invention;

FIG. 25

illustrates another embodiment of the probe of the present invention, specifically designed for creating incisions in external skin surfaces;

FIG. 26

is a perspective view of another embodiment of an electrosurgical probe for use in dermatology procedures;

FIGS. 27A-27C

are exploded, isometric views of the probe of

FIG. 26

;

FIG. 28

is a cross-sectional view of another alternative electrosurgical probe;

FIG. 29

illustrates another embodiment of the electrosurgical probe of the present invention, incorporating additional active electrodes;

FIG. 30

is a perspective view of an electrosurgical probe having a blade electrode;

FIG. 31A

is a perspective view, and

FIG. 31B

is a lateral view, of a blade electrode, according to one embodiment of the invention;

FIGS. 32A

,

32

B, and

32

C are a side view, a plan view, and an end view, respectively, of an electrosurgical probe having a blade electrode;

FIGS. 33A and 33B

are a side view and a plan view, respectively, of the distal end of an electrosurgical probe having a terminal blade electrode, according to one embodiment of the invention;

FIGS. 33C-33E

each show a side view of the distal end of an electrosurgical probe having a terminal blade electrode, according to three different embodiments of the invention;

FIGS. 34A

,

34

B, and

34

C are a side view, a plan view, and an end view, respectively, of an electrosurgical probe having a terminal electrode support and a lateral blade electrode, according to another embodiment of the invention;

FIGS. 35A

,

35

B, and

35

C are a side view, a plan view, and an end view, respectively, of an electrosurgical probe having a lateral electrode support and a lateral blade electrode, according to another embodiment of the invention;

FIGS. 36A and 36B

each show a side view of the distal end of an electrosurgical probe having a blade electrode, according to two different embodiments of the invention;

FIGS. 37A

, and

37

B are a side view and an end view, respectively, of an electrosurgical probe having a lumen external to the probe shaft, according to one embodiment of the invention;

FIGS. 38A

, and

38

B are a side view and an end view, respectively, of an electrosurgical probe having an outer sheath surrounding the probe shaft, according to another embodiment of the invention;

FIGS. 39A

,

39

B, and

39

C schematically represent a perspective view, a longitudinal sectional view, and an end view, respectively, of an electrosurgical probe, according to another embodiment of the invention;

FIG. 39D

shows detail of the distal portion of the probe of

FIGS. 39A-C

;

FIGS. 40A and 40B

schematically represent a longitudinal sectional view, and an end view, respectively, of an electrosurgical probe, according to another embodiment of the invention;

FIG. 40C

shows detail of the distal portion of the probe of

FIGS. 40A

,

40

B;

FIGS. 41A

,

41

B, and

41

C each show detail of the distal portion of an electrosurgical probe, according to three different embodiments of the invention;

FIGS. 42A and 42B

schematically represent a procedure for incising and coagulating tissue with an electrosurgical probe having a blade electrode, according to one embodiment of the invention;

FIG. 43A

schematically represents a number of steps involved in a method of treating a patient with an electrosurgical probe having a blade electrode, according to one embodiment of the invention;

FIG. 43B

schematically represents a number of steps involved in a method of concurrently severing and coagulating tissue, according to one embodiment of the invention; and

FIG. 44

schematically represents a number of steps involved in a method of dissecting a tissue or organ of a patient with an electrosurgical probe, according to another embodiment of the invention.

DESCRIPTION OF THE SPECIFIC EMBODIMENTS

The present invention provides systems and methods for selectively applying electrical energy to a target location within or on a patient's body, particularly for cutting, ablating, and/or coagulating a tissue using a blade-like electrode. The instant invention also provides apparatus and methods for making incisions to access a tissue or organ within a patient's body, to dissect or harvest the tissue or organ from the patient, and to transect or otherwise modify the tissue or organ. In one aspect, the invention provides apparatus and methods for dissecting and harvesting blood vessels from a patient.

The present invention is useful in procedures where the target tissue or organ is, or can be, flooded or submerged with an electrically conductive fluid, such as isotonic saline. In addition, tissues which may be treated by the system and method of the present invention further include, but are not limited to, tissues of the heart, chest, knee, shoulder, ankle, hip, elbow, hand or foot; as well as prostate tissue, leiomyomas (fibroids) located within the uterus, gingival tissues and mucosal tissues located in the mouth, tumors, scar tissue, myocardial tissue, collagenous tissue within the eye; together with epidermal and dermal tissues on the surface of the skin. The present invention is also useful for resecting tissue within accessible sites of the body that are suitable for electrode loop resection, such as the resection of prostate tissue, leiomyomas (fibroids) located within the uterus, or other tissue to be removed from the body.

The present invention is also useful for procedures in the head and neck, such as the ear, mouth, throat, pharynx, larynx, esophagus, nasal cavity, and sinuses. These procedures may be performed through the mouth or nose using speculae or gags, or using endoscopic techniques, such as functional endoscopic sinus surgery (FESS). These procedures may include the removal of swollen tissue, chronically-diseased inflamed and hypertrophic mucus linings, polyps and/or neoplasms from the various anatomical sinuses of the skull, the turbinates and nasal passages, in the tonsil, adenoid, epi-glottic and supra-glottic regions, and salivary glands, submucus resection of the nasal septum, excision of diseased tissue and the like. In other procedures, the present invention may be useful for cutting, resection, ablation and/or hemostasis of tissue in procedures for treating snoring and obstructive sleep apnea (e.g., UPPP procedures), for gross tissue removal, such as tonsillectomies, adenoidectomies, tracheal stenosis and vocal cord polyps and lesions, or for the resection or ablation of facial tumors or tumors within the mouth and pharynx, such as glossectomies, laryngectomies, acoustic neuroma procedures and nasal ablation procedures. In addition, the present invention is useful for procedures within the ear, such as stapedotomies, tympanostomies, myringotomies, or the like.

The present invention may also be useful for cosmetic and plastic surgery procedures in the head and neck. For example, the present invention is particularly useful for ablation and sculpting of cartilage tissue, such as the cartilage within the nose that is sculpted during rhinoplasty procedures. The present invention may also be employed for skin tissue removal and/or collagen shrinkage in the epidermis or dermis tissue in the head and neck region, e.g., the removal of pigmentations, vascular lesions, scars, tattoos, etc., and for other surgical procedures on the skin, such as tissue rejuvenation, cosmetic eye procedures (blepharoplasties), wrinkle removal, tightening muscles for facelifts or browlifts, hair removal and/or transplant procedures, etc.

The present invention is also useful for harvesting blood vessels, such as a blood vessel to be used as a graft vessel during the CABG procedure, e.g., the saphenous vein and the internal mammary artery (IMA). One or more embodiments of the invention may be used as follows: i) to access the blood vessel to be harvested, e.g., by opening the leg to access the saphenous vein, or opening the chest (either via a longitudinal incision of the sternum during an open-chest procedure, or during a minimally invasive inter-costal procedure); ii) to dissect the blood vessel to be harvested from the surrounding connective tissue along at least a portion of its length; and iii) to transect the dissected blood vessel at a first position only in the case of a pedicled graft (IMA), or at the first position and at a second position in the case of a free graft (saphenous vein). In each case i) to iii), as well as for other embodiment of the invention, the procedure involves removal of tissue by a cool ablation procedure in which a high frequency voltage is applied to an active electrode in the vicinity of a target tissue, typically in the presence of an electrically conductive fluid. The cool ablation procedure of the invention is described fully elsewhere herein. The electrically conductive fluid may be a bodily fluid such as blood or synovial fluid, intracellular fluid of the target tissue, or isotonic saline delivered to the target tissue during the procedure. The present invention is also useful for coagulating blood or blood vessels, for example, to minimize bleeding in the sternum during an open-chest procedure.

Although certain parts of this disclosure are directed specifically to creating incisions for accessing a patient's thoracic cavity and the harvesting and dissection of blood vessels within the body during a CABG procedure, systems and methods of the invention are equally applicable to other procedures involving other organs or tissues of the body, including minimally invasive procedures (e.g., minimally invasive CABG procedures), other open procedures, intravascular procedures, urological procedures, laparascopy, arthroscopy, thoracoscopy or other cardiac procedures, cosmetic surgery, orthopedics, gynecology, otorhinolaryngology, spinal and neurologic procedures, oncology, and the like.

In methods of the present invention, high frequency (RF) electrical energy is usually applied to one or more active electrodes in the presence of an electrically conductive fluid to remove and/or modify target tissue, an organ, or a body structure. Depending on the specific procedure, the present invention may be used to: (1) create incisions in tissue; (2) dissect or harvest tissue; (3) volumetrically remove tissue or cartilage (i.e., ablate or effect molecular dissociation of the tissue); (4) cut, transect, or resect tissue or an organ (e.g., a blood vessel); (5) create perforations or holes within tissue; and/or (6) coagulate blood and severed blood vessels.

In one method of the present invention, the tissue structures are incised by volumetrically removing or ablating tissue along a cutting path. In this procedure, a high frequency voltage difference is applied between one or more active electrode (s) and one or more return electrode(s) to develop high electric field intensities in the vicinity of the target tissue site. The high electric field intensities lead to electric field induced molecular breakdown of target tissue through molecular dissociation (rather than thermal evaporation or carbonization). Applicant believes that the tissue structure is volumetrically removed through molecular disintegration of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxides of carbon, hydrocarbons and nitrogen compounds. This molecular disintegration completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue, as is typically the case with electrosurgical desiccation and vaporization.

The high electric field intensities may be generated by applying a high frequency voltage that is sufficient to vaporize an electrically conductive fluid over at least a portion of the active electrode(s) in the region between the tip of the active electrode(s) and the target tissue. The electrically conductive fluid may be a gas or liquid, such as isotonic saline, delivered to the target site, or a viscous fluid, such as a gel, that is located at the target site. In the latter embodiment, the active electrode(s) are submersed in the electrically conductive gel during the surgical procedure. Since the vapor layer or vaporized region has a relatively high electrical impedance, it minimizes the current flow into the electrically conductive fluid. Within the vaporized fluid a plasma is formed, and charged particles (e.g., electrons) cause the localized molecular dissociation or disintegration of components of the target tissue, to a depth of perhaps several cell layers. This molecular dissociation results in the volumetric removal of tissue from the target site. This ablation process, which typically subjects the target tissue to a temperature in the range of 40° C. to 70° C., can be precisely controlled to effect the removal of tissue to a depth as little as about 10 microns, with little or no thermal or other damage to surrounding tissue. This cool ablation phenomenon has been termed Coblation®.

While not being bound by theory, applicant believes that the principle mechanism of tissue removal in the Coblation® mechanism of the present invention is energetic electrons or ions that have been energized in a plasma adjacent to the active electrode(s). When a liquid is heated sufficiently that atoms vaporize from the liquid at a greater rate than they recondense, a gas is formed. When the gas is heated sufficiently that the atoms collide with each other and electrons are removed from the atoms in the process, an ionized gas or plasma is formed. (A more complete description of plasmas (the so-called “fourth state of matter”) can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.) When the density of the vapor layer (or within a bubble formed in the electrically conductive liquid) becomes sufficiently low (i.e., less than approximately 10

20

atoms/cm

3

for aqueous solutions), the electron mean free path increases to enable subsequently injected electrons to cause impact ionization within these regions of low density (i.e., vapor layers or bubbles). Once the ionic particles in the plasma layer have sufficient energy, they accelerate towards the target tissue. Energy evolved by the energetic electrons (e.g., 3.5 eV to 5 eV) can subsequently bombard a molecule and break its bonds, dissociating a molecule into free radicals, which then combine into final gaseous or liquid species.

Plasmas may be formed by heating and ionizing a gas by driving an electric current through it, or by transmitting radio waves into the gas. Generally, these methods of plasma formation give energy to free electrons in the plasma directly, and then electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. Often, the electrons carry the electrical current or absorb the radio waves and, therefore, are hotter than the ions. Thus, in applicant's invention, the electrons, which are carried away from the tissue towards the return electrode, carry most of the plasma's heat with them, allowing the ions to break apart the tissue molecules in a substantially non-thermal manner.

The energy evolved by the energetic electrons may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and sharp edges on the electrode surfaces; electrode materials; applied voltage and power; current limiting means, such as inductors; electrical conductivity of the fluid in contact with the electrodes; density of the fluid; electrical insulators over the electrodes; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Since different tissue structures have different molecular bonds, the present invention can be configured to break the molecular bonds of certain tissue, while having too low an energy to break the molecular bonds of other tissue. For example, fatty tissue, (e.g., adipose tissue) contains a large amount of lipid material having double bonds, the breakage of which requires an energy level substantially higher than 4 eV to 5 eV. Accordingly, the present invention can be configured such that lipid components of adipose tissue are selectively not ablated. Of course, the present invention may be used to effectively ablate cells of adipose tissue such that the inner fat content of the cells is released in a liquid form. Alternatively, the invention can be configured (e.g., by increasing the voltage or changing the electrode configuration to increase the current density at the electrode tips) such that the double bonds of lipid materials are readily broken leading to molecular dissociation of lipids into low molecular weight condensable gases, generally as described hereinabove. A more complete description of the Coblation® phenomenon can be found in commonly assigned U.S. Pat. No. 5,683,366 and co-pending U.S. patent application Ser. No. 09/032,375, filed Feb. 27, 1998, the complete disclosures of which are incorporated herein by reference.

Methods of the present invention typically involve the application of high frequency (RF) electrical energy to one or more active electrodes in the presence of an electrically conductive fluid to remove (i.e., resect, incise, perforate, cut, or ablate) a target tissue, structure, or organ; and/or to seal transected vessels within the region of the target tissue. The present invention is particularly useful for sealing larger arterial vessels, e.g., having a diameter on the order of 1 mm or greater. In some embodiments, a high frequency power supply is provided having an ablation mode, wherein a first voltage is applied to an active electrode sufficient to effect molecular dissociation or disintegration of the tissue; and a coagulation mode, wherein a second, lower voltage is applied to an active electrode (either the same or a different electrode) sufficient to achieve hemostasis of severed vessels within the tissue. In other embodiments, an electrosurgical probe is provided having one or more coagulation electrode(s) configured for sealing a severed vessel, such as an arterial vessel, and one or more active electrodes configured for either contracting the collagen fibers within the tissue or removing (ablating) the tissue, e.g., by applying sufficient energy to the tissue to effect molecular dissociation. In the latter embodiments, the coagulation electrode(s) may be configured such that a single voltage can be applied to both coagulate with the coagulation electrode(s), and to ablate or contract tissue with the active electrode(s). In other embodiments, the power supply is combined with the coagulation probe such that the coagulation electrode is used when the power supply is in the coagulation mode (low voltage), and the active electrode(s) are used when the power supply is in the ablation mode (higher voltage).

In one method of the present invention, one or more active electrodes are brought into close proximity to tissue at a target site, and the power supply is activated in the ablation mode such that sufficient voltage is applied between the active electrodes and the return electrode to volumetrically remove the tissue through molecular dissociation, as described above. During this process, vessels within the tissue are severed. Smaller vessels may be automatically sealed with the system and method of the present invention. Larger vessels and those with a higher flow rate, such as arterial vessels, may not be automatically sealed in the ablation mode. In these cases, the severed vessels may be sealed by actuating a control (e.g., a foot pedal) to reduce the voltage of the power supply into the coagulation mode. In this mode, the active electrodes may be pressed against the severed vessel to provide sealing and/or coagulation of the vessel. Alternatively, a coagulation electrode located on the same or a different probe may be pressed against the severed vessel. Once the vessel is adequately sealed, the surgeon may activate a control (e.g., another foot pedal) to increase the voltage of the power supply back into the ablation mode.

The present invention is also useful for removing or ablating tissue around nerves, such as spinal, or cranial nerves, e.g., the hypoglossal nerve, the optic nerve, facial nerves, vestibulocochlear nerves and the like. This is particularly advantageous when removing tissue that is located close to nerves. One of the significant drawbacks with the conventional RF devices, scalpels, and lasers is that these devices do not differentiate between the target tissue and the surrounding nerves or bone. Therefore, the surgeon must be extremely careful during these procedures to avoid damage to the nerves within and around the target tissue. In the present invention, the Coblation® process for removing tissue results in no, or extremely small amounts, of collateral tissue damage, as described above. This allows the surgeon to remove tissue close to a nerve without causing collateral damage to the nerve fibers and surrounding tissue.

In addition to the generally precise nature of the novel mechanisms of the present invention, applicant has discovered an additional method of ensuring that adjacent nerves are not damaged during tissue removal. According to the present invention, systems and methods are provided for distinguishing between the fatty tissue immediately surrounding nerve fibers and the normal tissue that is to be removed during the procedure. Peripheral nerves usually comprise a connective tissue sheath, or epineurium, enclosing the bundles of nerve fibers, each bundle being surrounded by its own sheath of connective tissue (the perineurium) to protect these nerve fibers. The outer protective tissue sheath or epineurium typically comprises a fatty tissue (e.g., adipose tissue) having substantially different electrical properties than the normal target tissue that is treated. The system of the present invention measures the electrical properties of the tissue at the tip of the probe with one or more active electrode(s). These electrical properties may include electrical conductivity at one, several, or a range of frequencies (e.g., in the range from 1 kHz to 100 MHz), dielectric constant, capacitance or combinations of these. In this embodiment, an audible signal may be produced when the sensing electrode(s) at the tip of the probe detects the fatty tissue surrounding a nerve, or direct feedback control can be provided to only supply power to the active electrode(s) either individually or to the complete array of electrodes, if and when the tissue encountered at the tip or working end of the probe is normal tissue based on the measured electrical properties.

In one embodiment, the current limiting elements are configured such that the active electrodes will shut down or turn off when the electrical impedance reaches a threshold level. When this threshold level is set to the impedance of the fatty tissue surrounding nerves, the active electrodes will shut off whenever they come in contact with, or in close proximity to, nerves. Meanwhile, the other active electrodes, which are in contact with or in close proximity to target tissue, will continue to conduct electric current to the return electrode. This selective ablation or removal of lower impedance tissue in combination with the Coblation® mechanism of the present invention allows the surgeon to precisely remove tissue around nerves or bone. Applicant has found that the present invention is capable of volumetrically removing tissue closely adjacent to nerves without impairing the function of the nerves, and without significantly damaging the tissue of the epineurium.

The present invention can be also be configured to create an incision in a bone of the patient. For example, the systems of the present invention can be used to create an incision in the sternum for access to the thoracic cavity. Applicant has found that the Coblation® mechanism of the present invention allows the surgeon to precisely create an incision in the sternum while minimizing or preventing bone bleeding. The high frequency voltage is applied between the active electrode(s) and the return electrode(s) to volumetrically remove the bone from a specific site targeted for the incision. As the active electrode(s) are passed through the incision in the bone, the sides of the active electrodes (or a third coagulation electrode) slidingly contact the bone surrounding the incision to provide hemostasis in the bone. A more complete description of such coagulation electrodes can be found in U.S. patent application Ser. No. 09/162,117, filed Sep. 28, 1998, the complete disclosure of which is incorporated herein by reference.

The present invention can also be used to dissect and harvest blood vessels from the patient's body during a CABG procedure. The system of the present invention allows a surgeon to dissect and harvest blood vessels, such as the right or left IMA or saphenous vein, while concurrently providing hemostasis at the harvesting site. In some embodiments, a first high frequency voltage, can be delivered in an ablation mode to effect molecular disintegration of connective tissue adjacent to the blood vessel targeted for harvesting; and a second, lower voltage can be delivered to achieve hemostasis of the connective tissue adjacent to the blood vessel. In other embodiments, the targeted blood vessel can be transected at one or more positions along its length, and one or more coagulation electrode(s) can be used to seal the transected blood vessel at the site of transection. The coagulation electrode(s) may be configured such that a single voltage can be applied to the active electrodes to ablate the tissue and to coagulate the blood vessel and target site.

The present invention also provides systems, apparatus, and methods for selectively removing tumors or other undesirable body structures while minimizing the spread of viable cells from the tumor. Conventional techniques for removing such tumors generally result in the production of smoke in the surgical setting, termed an electrosurgical or laser plume, which can spread intact, viable bacterial or viral particles from the tumor or lesion to the surgical team, or viable cancerous cells to other locations within the patient's body. This potential spread of viable cells or particles has resulted in increased concerns over the proliferation of certain debilitating and fatal diseases, such as hepatitis, herpes, HIV and papillomavirus. In the present invention, high frequency voltage is applied between the active electrode(s) and one or more return electrode(s) to volumetrically remove at least a portion of the tissue cells in the tumor or lesion by the molecular dissociation of tissue components into non-condensable gases. The high frequency voltage is preferably selected to effect controlled removal of these tissue cells while minimizing substantial tissue necrosis to surrounding or underlying tissue. A more complete description of this phenomenon can be found in copending U.S. patent application Ser. No. 09/109,219, filed Jun. 30, 1998, the complete disclosure of which is incorporated herein by reference.

A current flow path between the active electrode(s) and the return electrode(s) may be generated by submerging the tissue site in an electrically conductive fluid (e.g., within a viscous fluid, such as an electrically conductive gel) or by directing an electrically conductive fluid along a fluid path to the target site (i.e., a liquid, such as isotonic saline, or a gas, such as argon). This latter method is particularly effective in a dry field procedure (i.e., the tissue is not submersed in fluid). The use of a conductive gel allows a slower, more controlled delivery rate of conductive fluid as compared with a liquid or a gas. In addition, the viscous nature of the gel may allow the surgeon to more easily contain the gel around the target site (e.g., as compared with containment of isotonic saline). A more complete description of an exemplary method of directing electrically conductive fluid between the active and return electrodes is described in U.S. Pat. No. 5,697,281, the full disclosure of which is incorporated herein by reference. Alternatively, the body's natural conductive fluids, such as blood, may be sufficient to establish a conductive path between the return electrode(s) and the active electrode(s), and to provide the conditions for establishing a vapor layer, as described above. However, conductive fluid that is introduced into the patient is generally preferred over blood because blood will tend to coagulate at certain temperatures. Advantageously, a liquid electrically conductive fluid (e.g., isotonic saline) may be used to concurrently “bathe” the target tissue surface to provide an additional means for removing any tissue, and to cool the tissue at or adjacent to the target site.

In some embodiments of the invention, an electrosurgical probe includes an electrode support for electrically isolating the active electrode(s) from the return electrode, and a fluid delivery port or outlet for directing an electrically conductive fluid to the target site or to the distal end of the probe. The electrode support and the fluid outlet may be recessed from an outer surface of the instrument to confine the electrically conductive fluid to the region immediately surrounding the electrode support. In addition, a shaft of the instrument may be shaped so as to form a cavity around the electrode support and the fluid outlet. This helps to assure that the electrically conductive fluid will remain in contact with the active electrode(s) and the return electrode(s) to maintain the conductive path therebetween. In addition, this will help to maintain a vapor layer and subsequent plasma layer between the active electrode(s) and the tissue at the treatment site throughout the procedure, thereby reducing any thermal damage that might otherwise occur if the vapor layer were extinguished due to a lack of conductive fluid. Provision of the electrically conductive fluid around the target site also helps to maintain the tissue temperature at desired levels.

The electrically conductive fluid should have a threshold conductivity to provide a suitable conductive path between the return electrode and the active electrode(s). The electrical conductivity of the fluid (in units of milliSiemens per centimeter or mS/cm) will usually be greater than 0.2 mS/cm, preferably will be greater than 2 mS/cm and more preferably greater than 10 mS/cm. In an exemplary embodiment, the electrically conductive fluid is isotonic saline, which has a conductivity of about 17 mS/cm.

An electrosurgical probe or instrument of the invention typically includes a shaft having a proximal end and a distal end, and one or more active electrode(s) disposed at the shaft distal end., The shaft serves to mechanically support the active electrode(s) and permits the treating physician to manipulate the shaft distal end via a handle attached to the proximal end of the shaft. The shaft may be rigid or flexible, with flexible shafts optionally being combined with a generally rigid external tube for mechanical support. Flexible shafts may be combined with pull wires, shape memory actuators, and other known mechanisms for effecting selective deflection of the distal end of the shaft to facilitate positioning of the electrode array. The shaft will usually have one or more wires, electrode connectors, leads, or other conductive elements running axially therethrough, to permit connection of the electrode(s) to a connection block located at the proximal end of the instrument. The connection block is adapted for coupling the electrode(s) to the power supply or controller. Typically, the connection block is housed within the handle of the probe.

The shaft of an instrument under the invention may assume various configurations. Generally, the shaft will have a suitable diameter and length to allow the surgeon to access the target site with the distal or working end of the shaft. Thus, the shaft may be provided in a range of sizes according to the particular procedure or tissue targeted for treatment. Typically, the shaft will have a length in the range of from about 5 cm to 30 cm, and have a diameter in the range of from about

—

0.5 mm to 10 mm. Specific shaft designs will be described in detail in connection with the drawings hereinafter.

The present invention may use a single active electrode or a plurality of electrodes distributed across a contact surface of a probe (e.g., in a linear fashion). In the latter embodiment, the electrode array usually includes a plurality of independently current-limited and/or power-controlled active electrodes to apply electrical energy selectively to the target tissue while limiting the unwanted application of electrical energy to the surrounding tissue and environment resulting from power dissipation into surrounding electrically conductive liquids, such as blood, normal saline, electrically conductive gel and the like. The active electrodes may be independently current-limited by isolating the terminals from each other and connecting each terminal to a separate power source that is isolated from the other active electrodes. Alternatively, the active electrodes may be connected to each other at either the proximal or distal ends of the probe to form a single wire that couples to a power source.

In one configuration, each individual active electrode is electrically insulated from all other active electrodes within the probe and is connected to a power source which is isolated from each of the other active electrodes in the array, or to circuitry which limits or interrupts current flow to the active electrode when low resistivity material causes a low impedance path between the return electrode and the individual active electrode. The isolated power sources for each individual active electrode may be separate power supply circuits having internal impedance characteristics which limit power to the associated active electrode when a low impedance return path is encountered. By way of example, the isolated power source may be a user selectable constant current source. In this embodiment, lower impedance paths will automatically result in lower resistive heating levels since the heating is proportional to the square of the operating current times the impedance. Alternatively, a single power source may be connected to each of the active electrodes through independently actuatable switches, or by independent current limiting elements, such as inductors, capacitors, resistors and/or combinations thereof. The current limiting elements may be provided in the probe, connectors, cable, power supply or along the conductive path from the power supply to the distal tip of the probe. Alternatively, the resistance and/or capacitance may occur on the surface of the active electrode(s) due to oxide layers which form selected active electrodes (e.g., titanium or a resistive coating on the surface of metal, such as platinum).

The distal end of the probe may comprise many independent active electrodes designed to deliver electrical energy in the vicinity of the distal end. The selective application of electrical energy to the conductive fluid is achieved by connecting each individual active electrode and the return electrode to a power source having independently controlled or current limited channels. The return electrode(s) may comprise a single tubular member of electrically conductive material at the distal end of the probe proximal to the active electrode(s) The same tubular member of electrically conductive material may also serve as a conduit for the supply of the electrically conductive fluid between the active and return electrodes. The application of high frequency voltage between the return electrode(s) and the active electrode(s) results in the generation of high electric field intensities at the distal tip of the active electrode(s), with conduction of high frequency current from each active electrode to the return electrode. The current flow from each active electrode to the return electrode(s) is controlled by either active or passive means, or a combination thereof, to deliver electrical energy to the surrounding conductive fluid while minimizing energy delivery to surrounding (non-target) tissue.

The application of a suitable high frequency voltage between the return electrode(s) and the active electrode(s) for appropriate time intervals effects cutting, removing, ablating, shaping, contracting or otherwise modifying the target tissue. In one embodiment, the tissue volume over which energy is dissipated (i.e., over which a high current density exists) may be precisely controlled, for example, by the use of a multiplicity of small active electrodes whose effective diameters or principal dimensions range from about 5 mm to 0.01 mm, preferably from about 2 mm to 0.05 mm, and more preferably from about 1 mm to 0.1 mm. Electrode areas for both circular and non-circular terminals will have a contact area (per active electrode) below 25 mm

2

, preferably being in the range from 0.0001 mm

2

to 1 mm

2

, and more preferably from 0.005 mm

2

to 0.5 mm

2

. The circumscribed area of the electrode array is in the range from 0.25 mm

2

to 75 mm

2

, preferably from 0.5 mm

2

to 40 mm

2

. In one embodiment the probe may include a plurality of relatively small active electrodes disposed over the distal contact surfaces on the shaft. The use of small diameter active electrodes increases the electric field intensity and reduces the extent or depth of tissue heating as a consequence of the divergence of current flux lines which emanate from the exposed surface of each active electrode.

The portion of the electrode support on which the active electrode(s) are mounted generally defines a tissue treatment surface of the probe. The area of the tissue treatment surface can vary widely, and the tissue treatment surface can assume a variety of geometries, with particular areas and geometries being selected for specific applications. The area of the tissue treatment surface can range from about 0.25 mm

2

to 75 mm

2

, usually being from about 0.5 mm

2

to 40 mm

2

. The geometries of the active electrode(s) can be planar, concave, convex, hemispherical, conical, a linear “in-line” array, or virtually any other regular or irregular shape. Most commonly, the active electrode(s) will be located at the shaft distal end of the electrosurgical probe, frequently having planar, disk-shaped, or hemispherical surfaces for use in reshaping procedures, ablating, cutting, dissecting organs, coagulating, or transecting blood vessels. The active electrode(s) may be arranged terminally or laterally on the electrosurgical probe (e.g., in the manner of a scalpel or a blade). However, it should be clearly understood that the active electrode of the invention does not cut or sever tissue mechanically as for a scalpel blade, but rather by the localized molecular dissociation of tissue components due to application of high frequency electric current to the active electrode. In one embodiment, a distal portion of the shaft may be flattened or compressed laterally (e.g., FIGS.

32

A-

32

C). A probe having a laterally compressed shaft may facilitate access to certain target sites or body structures during various surgical procedures.

In embodiments having a plurality of active electrodes, it should be clearly understood that the invention is not limited to electrically isolated active electrodes. For example, a plurality of active electrodes may be connected to a single lead that extends through the probe shaft and is coupled to a high frequency power supply. Alternatively, the probe may incorporate a single electrode that extends directly through the probe shaft or is connected to a single lead that extends to the power source. The active electrode may have a planar or blade shape, a screwdriver or conical shape, a sharpened point, a ball shape (e.g., for tissue vaporization and desiccation), a twizzle shape (for vaporization and needle-like cutting), a spring shape (for rapid tissue debulking and desiccation), a twisted metal shape, an annular or solid tube shape, or the like. Alternatively, the electrode may comprise a plurality of filaments, a rigid or flexible brush electrode (for debulking a tumor, such as a fibroid, bladder tumor or a prostate adenoma), a side-effect brush electrode on a lateral surface of the shaft, a coiled electrode, or the like.

In one embodiment, the probe comprises a single blade active electrode that extends from an insulating support member, spacer, or electrode support, e.g., a ceramic or silicone rubber spacer located at the distal end of the probe. The insulating support member may be a tubular structure or a laterally compressed structure that separates the blade active electrode from a tubular or annular return electrode positioned proximal to the insulating member and the active electrode. The blade electrode may include a distal cutting edge and sides which are configured to coagulate the tissue as the blade electrode advances through the tissue. In yet another embodiment, the catheter or probe includes a single active electrode that can be rotated relative to the rest of the catheter body, or the entire catheter may be rotated relative to the electrode lead(s). The single active electrode can be positioned adjacent the abnormal tissue and energized and rotated as appropriate to remove or modify the target tissue.

The active electrode(s) are preferably supported within or by an insulating support member positioned near the distal end of the instrument shaft. The return electrode may be located on the instrument shaft, on another instrument, or on the external surface of the patient (i.e., a dispersive pad). For certain procedures, the close proximity of nerves and other sensitive tissue makes a bipolar design more preferable because this minimizes the current flow through non-target tissue and surrounding nerves. Accordingly, the return electrode is preferably either integrated with the instrument body, or located on another instrument. The proximal end of the probe typically includes the appropriate electrical connections for coupling the return electrode(s) and the active electrode(s) to a high frequency power supply, such as an electrosurgical generator.

One exemplary power supply of the present invention delivers a high frequency current selectable to generate average power levels ranging from several milliwatts to tens of watts per electrode, depending on the volume of target tissue being treated, and/or the maximum allowed temperature selected for the instrument tip. The power supply allows the user to select the voltage level according to the specific requirements of a particular otologic procedure, neurosurgery procedure, cardiac surgery, arthroscopic surgery, dermatological procedure, ophthalmic procedures, open surgery or other endoscopic surgery procedure. For cardiac procedures and potentially for neurosurgery, the power source may have an additional filter, for filtering leakage voltages at frequencies below 100 kHz, particularly voltages around 60 kHz. Alternatively, a power supply having a higher operating frequency, e.g., 300 kHz to 500 kHz may be used in certain procedures in which stray low frequency currents may be problematic. A description of one suitable power supply can be found in co-pending patent applications Ser. Nos. 09/058,571 and 09/058,336, filed Apr. 10, 1998, the complete disclosure of both applications are incorporated herein by reference for all purposes.

The voltage difference applied between the return electrode(s) and the active electrode(s) will be at high or radio frequency, typically between about 5 kHz and 20 MHz, usually being between about 30 kHz and 2.5 MHz, preferably being between about 50 kHz and 500 kHz, often less than 350 kHz, and often between about 100 kHz and 200 kHz. The RMS (root mean square) voltage applied will usually be in the range from about 5 volts to 1000 volts, preferably being in the range from about 10 volts to 500 volts depending on the active electrode size, the operating frequency, and the operation mode of the particular procedure or desired effect on the tissue (e.g., contraction, coagulation, cutting or ablation). Typically, the peak-to-peak voltage for ablation or cutting will be in the range of 10 volts to 2000 volts and preferably in the range of 200 volts to 1800 volts, and more preferably in the range of about 300 volts to 1500 volts, often in the range of about 500 volts to 900 volts peak to peak (again, depending on the electrode size, the operating frequency and the operation mode). Lower peak-to-peak voltages will be used for tissue coagulation or collagen contraction and will typically be in the range from 50 to 1500, preferably 100 to 1000, and more preferably 120 to 600 volts peak-to-peak.

The voltage is usually delivered in a series of voltage pulses or alternating current of time varying voltage amplitude with a sufficiently high frequency (e.g., on the order of 5 kHz to 20 MHz) such that the voltage is effectively applied continuously (as compared with e.g., lasers claiming small depths of necrosis, which are generally pulsed about 10 Hz to 20 Hz). In addition, the duty cycle (i.e., cumulative time in any one-second interval that energy is applied) is on the order of about 50% for the present invention, as compared with pulsed lasers which typically have a duty cycle of about 0.0001%.

The power supply may include a fluid interlock for interrupting power to the active electrode(s) when there is insufficient conductive fluid around the active electrode(s). This ensures that the instrument will not be activated when conductive fluid is not present, minimizing the tissue damage that may otherwise occur. A more complete description of such a fluid interlock can be found in commonly assigned, copending U.S. application Ser. No. 09/058,336, filed Apr. 10, 1998, the complete disclosure of which is incorporated herein by reference.

The power supply may also be current limited or otherwise controlled so that undesired heating of the target tissue or surrounding (non-target) tissue does not occur. In a presently preferred embodiment of the present invention, current limiting inductors are placed in series with each independent active electrode, where the inductance of the inductor is in the range of 10 uH to 50,000 uH, depending on the electrical properties of the target tissue, the desired tissue heating rate and the operating frequency. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described previously in U.S. Pat. No. 5,697,909, the complete disclosure of which is incorporated herein by reference. Additionally, current limiting resistors may be selected. Preferably, these resistors will have a large positive temperature coefficient of resistance so that, as the current level begins to rise for any individual active electrode in contact with a low resistance medium (e.g., saline irrigant or blood), the resistance of the current limiting resistor increases significantly, thereby minimizing the power delivery from the active electrode into the low resistance medium (e.g., saline irrigant or blood).

In some procedures, it may also be necessary to retrieve or aspirate the electrically conductive fluid and/or the non-condensable gaseous products of ablation. In addition, it may be desirable to aspirate small pieces of tissue or other body structures that are not completely disintegrated by the high frequency energy, or other fluids at the target site, such as blood, mucus, purulent fluid, the gaseous products of ablation, or the like. Accordingly, the system of the present invention may include one or more suction lumen(s) in the instrument, or on another instrument, coupled to a suitable vacuum source for aspirating fluids from the target site. In addition, the invention may include one or more aspiration electrode(s) coupled to the distal end of the suction lumen for ablating, or at least reducing the volume of, non-ablated tissue fragments that are aspirated into the lumen. The aspiration electrode(s) function mainly to inhibit clogging of the lumen that may otherwise occur as larger tissue fragments are drawn therein. The aspiration electrode(s) may be different from the ablation active electrode(s), or the same electrode(s) may serve both functions. A more complete description of instruments incorporating aspiration electrode(s) can be found in commonly assigned, co-pending patent application Ser. No. 09/010,382, filed Jan. 21, 1998, the complete disclosure of which is incorporated herein by reference.

During a surgical procedure, the distal end of the instrument and the active electrode(s) may be maintained at a small distance away from the target tissue surface. This small spacing allows for the continuous flow of electrically conductive fluid into the interface between the active electrode(s) and the target tissue surface. The continuous flow of the electrically conductive fluid helps to ensure that the thin vapor layer will remain between the active electrode(s) and the tissue surface. In addition, dynamic movement of the active electrode(s) over the tissue site allows the electrically conductive fluid to cool the tissue underlying and surrounding the target tissue to minimize thermal damage to this surrounding and underlying tissue. Accordingly, the electrically conductive fluid may be cooled to facilitate the cooling of the tissue. Typically, the active electrode(s) will be about 0.02 mm to 2 mm from the target tissue and preferably about 0.05 mm to 0.5 mm during the ablation process. One method of maintaining this space is to move, translate and/or rotate the probe transversely relative to the tissue, i.e., for the operator to use a light brushing motion, to maintain a thin vaporized layer or region between the active electrode and the tissue. Of course, if coagulation or collagen shrinkage of a deeper region of tissue is necessary (e.g., for sealing a bleeding vessel embedded within the tissue), it may be desirable to press the active electrode(s) against the tissue to effect joulean heating therein.

Referring to

FIG. 1

, an exemplary electrosurgical system

11

for cutting, ablating, resecting, or otherwise modifying tissue will now be described in detail. Electrosurgical system

11

generally comprises an electrosurgical handpiece or probe

10

connected to a power supply

28

for providing high frequency voltage to a target site, and a fluid source

21

for supplying electrically conductive fluid

50

to probe

10

. In addition, electrosurgical system

11

may include an endoscope (not shown) with a fiber optic head light for viewing the surgical site. The endoscope may be integral with probe

10

, or it may be part of a separate instrument. The system

11

may also include a vacuum source (not shown) for coupling to a suction lumen or tube

211

(see

FIG. 2

) in the probe

10

for aspirating the target site.

As shown, probe

10

generally includes a proximal handle

19

and an elongate shaft

18

having one or more active electrodes

58

at its distal end. A connecting cable

34

has a connector

26

for electrically coupling the active electrodes

58

to power supply

28

. In embodiments having a plurality of active electrodes, active electrodes

58

are electrically isolated from each other and the terminal of each active electrode

58

is connected to an active or passive control network within power supply

28

by means of a plurality of individually insulated conductors (not shown). A fluid supply tube

15

is connected to a fluid tube

14

of probe

10

for supplying electrically conductive fluid

50

to the target site.

Power supply

28

has an operator controllable voltage level adjustment

30

to change the applied voltage level, which is observable at a voltage level display

32

. Power supply

28

also includes first, second, and third foot pedals

37

,

38

,

39

and a cable

36

which is removably coupled to power supply

28

. The foot pedals

37

,

38

,

39

allow the surgeon to remotely adjust the energy level applied to active electrode(s)

58

. In an exemplary embodiment, first foot pedal

37

is used to place the power supply into the “ablation” mode and second foot pedal

38

places power supply

28

into the “coagulation” mode. The third foot pedal

39

allows the user to adjust the voltage level within the ablation mode. In the ablation mode, a sufficient voltage is applied to the active electrodes to establish the requisite conditions for molecular dissociation of the tissue (i.e., vaporizing a portion of the electrically conductive fluid, ionizing the vapor layer and accelerating charged particles against the tissue). As discussed above, the requisite voltage level for ablation will vary depending on the number, size, shape and spacing of the electrodes, the distance in which the electrodes extend from the support member, etc. When the surgeon is using the power supply in the ablation mode, voltage level adjustment

30

or third foot pedal

39

may be used to adjust the voltage level to adjust the degree or aggressiveness of the ablation.

Of course, it will be recognized that the voltage and modality of the power supply may be controlled by other input devices. However, applicant has found that foot pedals are convenient means for controlling the power supply while manipulating the probe during a surgical procedure.

In the coagulation mode, the power supply

28

applies a low enough voltage to the active electrode(s) (or the coagulation electrode) to avoid vaporization of the electrically conductive fluid and subsequent molecular dissociation of the tissue. The surgeon may automatically toggle the power supply between the ablation and coagulation modes by alternately stepping on foot pedals

37

,

38

, respectively. This allows the surgeon to quickly move between coagulation and ablation in situ, without having to remove his/her concentration from the surgical field or without having to request an assistant to switch the power supply. By way of example, as the surgeon is sculpting soft tissue in the ablation mode, the probe typically will simultaneously seal and/or coagulation small severed vessels within the tissue. However, larger vessels, or vessels with high fluid pressures (e.g., arterial vessels) may not be sealed in the ablation mode. Accordingly, the surgeon can simply step on foot pedal

38

, automatically lowering the voltage level below the threshold level for ablation, and apply sufficient pressure onto the severed vessel for a sufficient period of time to seal and/or coagulate the vessel. After this is completed, the surgeon may quickly move back into the ablation mode by stepping on foot pedal

37

. A specific design of a suitable power supply for use with the present invention can be found in Provisional Patent Application No. 60/062,997, filed Oct. 23, 1997, previously incorporated herein by reference.

FIG. 2

shows an electrosurgical probe

20

according to one embodiment of the invention. Probe

20

may be used in conjunction with a system similar or analogous to system

11

(FIG.

1

). As shown in

FIG. 2

, probe

20

generally includes an elongated shaft

100

which may be flexible or rigid, a handle

204

coupled to the proximal end of shaft

100

and an electrode support member

102

coupled to the distal end of shaft

100

. Shaft

100

may comprise a plastic material that is easily molded into the shape shown in

FIG. 3

, or shaft

100

may comprise an electrically conductive material, usually a metal, such as tungsten, stainless steel alloys, platinum or its alloys, titanium or its alloys, molybdenum or its alloys, and nickel or its alloys. In the latter case (i.e., shaft

100

is electrically conductive), probe

20

includes an electrically insulating jacket

108

, which is typically formed as one or more electrically insulating sheaths or coatings, such as polytetrafluoroethylene, polyimide, and the like. The provision of electrically insulating jacket

108

over shaft

100

prevents direct electrical contact between the metal shaft and any adjacent body structure or the surgeon. Such direct electrical contact between a body structure (e.g., heart, bone, nerves, skin, or other blood vessels) and an exposed electrode could result in unwanted heating and necrosis of the structure at the point of contact.

Handle

204

typically comprises a plastic material that is easily molded into a suitable shape for handling by the surgeon. Handle

204

defines an inner cavity (not shown) that houses an electrical connections unit

250

(FIG.

5

), and provides a suitable interface for coupling probe

20

to power supply

28

via an electrical connecting cable. Electrode support member

102

extends from the distal end of shaft

100

(usually about 1 mm to 20 mm), and provides support for an active electrode or a plurality of electrically isolated active electrodes

104

. In the specific configuration shown in

FIG. 2

, probe

20

includes a plurality of active electrodes. As shown in

FIG. 2

, a fluid tube

233

extends through an opening in handle

204

, and includes a connector

235

for connection to a fluid supply source for supplying electrically conductive fluid to the target site. Fluid tube

233

is coupled to a distal fluid tube

239

that extends along the outer surface of shaft

100

to an opening

237

at the distal end of the probe

20

, as will be discussed in detail below. Of course, the invention is not limited to this configuration. For example, fluid tube

233

may extend through a single lumen (not shown) in shaft

100

, it may be coupled to a plurality of lumens (also not shown) that extend through shaft

100

to a plurality of openings at its distal end, or the fluid tube may be completely independent of shaft

100

. Probe

20

may also include a valve or equivalent structure for controlling the flow rate of the electrically conductive fluid to the target site.

As shown in

FIGS. 3 and 4

, electrode support member

102

has a substantially planar tissue treatment surface

212

and comprises a suitable insulating material (e.g., a ceramic or glass material, such as alumina, zirconia and the like) which could be formed at the time of manufacture in a flat, hemispherical or other shape according to the requirements of a particular procedure. The preferred support member material is alumina (Kyocera Industrial Ceramics Corporation, Elkgrove, Ill.), because of its high thermal conductivity, good electrically insulative properties, high flexural modulus, resistance to carbon tracking, biocompatibility, and high melting point. Electrode support member

102

is adhesively joined to a tubular support member (not shown) that extends most or all of the distance between support member

102

and the proximal end of probe

20

. The tubular member preferably comprises an electrically insulating material, such as an epoxy or silicone-based material.

In a preferred construction technique, active electrodes

104

extend through pre-formed openings in the support member

102

so that they protrude above tissue treatment surface

212

by the desired distance. The electrodes are then bonded to the tissue treatment surface

212

of support member

102

, typically by an inorganic sealing material. The sealing material is selected to provide effective electrical insulation, and good adhesion to both support member

102

and active electrodes

104

. In one embodiment, active electrodes

104

comprise an electrically conducting, corrosion resistant metal, such as platinum or titanium. The sealing material additionally should have a compatible thermal expansion coefficient and a melting point well below that of platinum or titanium and alumina or zirconia, typically being a glass or glass ceramic.

In the embodiment shown in

FIGS. 2-5

, probe

20

includes a return electrode

112

for completing the current path between active electrodes

104

and a high frequency power supply

28

(see FIG.

1

). As shown, return electrode

112

preferably comprises an annular conductive band coupled to the distal end of shaft

100

at a location proximal to tissue treatment surface

212

of electrode support member

102

, typically about 0.5 mm to 10 mm proximal to surface

212

, and more preferably about 1 mm to 10 mm proximal to surface

212

. Return electrode

112

is coupled to a connector

258

that extends to the proximal end of probe

20

, where it is suitably connected to power supply

28

(FIGS.

1

and

2

).

As shown in

FIG. 2

, return electrode

112

is not directly connected to active electrodes

104

. To complete this current path so that active electrodes

104

are electrically connected to return electrode

112

, electrically conductive fluid (e.g., isotonic saline) is caused to flow therebetween. In the representative embodiment, the electrically conductive fluid is delivered through an external fluid tube

239

to opening

237

, as described above (FIGS.

2

and

4

). Alternatively, the fluid may be continuously delivered by a fluid delivery element (not shown) that is separate from probe

20

.

In alternative embodiments, the fluid path may be formed in probe

20

by, for example, an inner lumen or an annular gap between the return electrode and a tubular support member within shaft

100

(not shown). This annular gap may be formed near the perimeter of the shaft

100

such that the electrically conductive fluid tends to flow radially inward towards the target site, or it may be formed towards the center of shaft

100

so that the fluid flows radially outward. In both of these embodiments, a fluid source (e.g., a bag of fluid elevated above the surgical site or having a pumping device), is coupled to probe

20

via a fluid supply tube (not shown) that may or may not have a controllable valve. A more complete description of an electrosurgical probe incorporating one or more fluid lumen(s) can be found in U.S. Pat. No. 5,697,281, filed on Jun. 7, 1995, the complete disclosure of which is incorporated herein by reference.

Referring to

FIGS. 3 and 4

, the electrically isolated active electrodes

104

are preferably spaced from each other and aligned to form a linear array

105

of electrodes for cutting a substantially linear incision in the tissue. The tissue treatment surface and individual active electrodes

104

will usually have dimensions within the ranges set forth above. Active electrodes

104

preferably have a distal edge

107

to increase the electric field intensities around terminals

104

, and to facilitate cutting of tissue. Thus, active electrodes

104

have a screwdriver shape in the representative embodiment of

FIGS. 2-4

. In one representative embodiment, the tissue treatment surface

212

has a circular cross-sectional shape with a diameter in the range of about 1 mm to 30 mm, usually about 2 mm to 20 mm. The individual active electrodes

104

preferably extend outward from tissue treatment surface

212

by a distance of about 0.1 mm to 8 mm, usually about 1 mm to 4 mm. Applicant has found that this configuration increases the high electric field intensities and associated current densities around active electrodes

104

to facilitate the ablation of tissue as described in detail above.

Probe

20

may include a suction or aspiration lumen

213

(see

FIG. 2

) within shaft

100

and a suction tube

211

(

FIG. 2

) for aspirating tissue, fluids and/or gases from the target site. In this embodiment, the electrically conductive fluid generally flows from opening

237

of fluid tube

239

radially inward and then back through one or more openings (not shown) in support member

102

. Aspirating the electrically conductive fluid during surgery allows the surgeon to see the target site, and it prevents the fluid from flowing into the patient's body (e.g., the thoracic cavity). This aspiration should be controlled, however, so that the conductive fluid maintains a conductive path between the active electrode(s) and the return electrode. In some embodiments, the probe

20

will also include one or more aspiration electrode(s) (not shown) coupled to the aspiration lumen for inhibiting clogging during aspiration of tissue fragments from the surgical site. A more complete description of these embodiments can be found in commonly assigned co-pending U.S. patent application Ser. No. 09/010,382, filed Jan. 21, 1998, the complete disclosure of which is incorporated herein by reference for all purposes.

FIG. 5

illustrates the electrical connections

250

within handle

204

for coupling active electrodes

104

and return electrode

112

to the power supply

28

. As shown, a plurality of wires

252

extend through shaft

100

to couple electrodes

104

to a plurality of pins

254

, which are plugged into a connector block

256

for coupling to a connecting cable

22

(FIG.

1

). Similarly, return electrode

112

is coupled to connector block

256

via a wire

258

and a plug

260

.

According to the present invention, probe

20

further includes an identification element that is characteristic of the particular electrode assembly so that the same power supply

28

can be used for different electrosurgical operations. In one embodiment, for example, probe

20

includes a voltage reduction element or a voltage reduction circuit for reducing the voltage applied between the active electrodes

104

and the return electrode

112

. The voltage reduction element serves to reduce the voltage applied by the power supply so that the voltage between the active electrodes and the return electrode is low enough to avoid excessive power dissipation into the electrically conductive medium and/or the tissue at the target site. The voltage reduction element primarily allows the electrosurgical probe

10

/

20

to be compatible with a range of different power supplies that are adapted to apply higher voltages for ablation or vaporization of tissue (e.g., various power supplies or generators manufactured by ArthroCare Corporation, Sunnyvale, Calif.). For contraction of tissue, for example, the voltage reduction element will serve to reduce a voltage of about 100 to 135 volts RMS (which corresponds to a setting of 1 on the ArthroCare Model 970 and 980 (i.e., 2000) Generators) to about 45 to 60 volts RMS, which is a suitable voltage for contraction of tissue without ablation (e.g., molecular dissociation) of the tissue.

Again with reference to

FIG. 5

, n the representative embodiment the voltage reduction element is a dropping capacitor

262

which has a first leg

264

coupled to the return electrode wire

258

and a second leg

266

coupled to connector block

256

. Of course, the capacitor may be located in other places within the system, such as in, or distributed along the length of, the cable, the power supply, the connector, etc. In addition, it will be recognized that other voltage reduction elements, such as diodes, transistors, inductors, resistors, capacitors or combinations thereof, may be used in conjunction with the present invention. For example, probe

20

may include a coded resistor (not shown) that is constructed to lower the voltage applied between return electrode

112

and active electrodes

104

to a suitable level for contraction of tissue. In addition, electrical circuits may be employed for this purpose.

Alternatively or additionally, the cable

22

that couples the power supply

28

to probe

10

/

20

may be used as a voltage reduction element. The cable has an inherent capacitance that can be used to reduce the power supply voltage if the cable is placed into the electrical circuit between the power supply, the active electrodes and the return electrode. In this embodiment, the cable

22

may be used alone, or in combination with one of the voltage reduction elements discussed above, e.g., a capacitor.

Further, it should be noted that various electrosurgical probes of the present invention can be used with a particular power supply that is adapted to apply a voltage within a selected range for a certain procedure or treatment. In which case, a voltage reduction element or circuitry may not be necessary nor desired.

With reference to

FIGS. 6-8

, electrode support member

70

according to one embodiment includes a multi-layer substrate comprising a suitable high temperature, electrically insulating material, such as ceramic. The multi-layer substrate is a thin or thick-film hybrid having conductive strips that are adhered to the ceramic wafer layers (e.g., thick-film printed and fired onto or plated onto the ceramic wafers). The conductive strips typically comprise tungsten, gold, nickel, silver, platinum or equivalent materials. In the exemplary embodiment, the conductive strips comprise tungsten, and they are co-fired together with the wafer layers to form an integral package. The conductive strips are coupled to external wire connectors by holes or vias that are drilled through the ceramic layers, and plated or otherwise covered with conductive material. A more complete description of such support members

370

can be found in U.S. patent application Ser. No. 08/977,845, filed Nov. 25, 1997, the entire disclosure of which is incorporated herein by reference.

In the representative embodiment, support member

70

comprises five ceramic layers

200

,

202

,

204

,

206

,

208

(see FIGS.

6

-

10

), three gold plated active electrodes

210

a

,

210

b

,

210

c

and first and second gold plated return electrodes

216

,

218

. As shown in

FIGS. 9A and 9B

, a first ceramic layer

200

, which is one of the outer layers of support

70

, includes first gold plated return electrode

216

on a lateral surface

220

of layer

200

. First ceramic layer

200

further includes a gold conductive strip

222

extending from return electrode

216

to the proximal end of layer

200

for coupling to a lead wire (not shown), and three gold conductive lines

224

,

226

,

228

extending from a mid-portion of layer

200

to its proximal end. Conductive strips

224

,

226

,

228

are each coupled to one of the active electrodes

210

a

,

210

b

,

210

c

by conductive holes or vias

230

,

232

,

234

, respectively. As shown, all three vias

230

,

232

,

234

extend through wafer layer

200

.

Referring to

FIGS. 10A and 10B

, a second wafer layer

202

is bonded between first outer wafer layer

200

and a middle wafer layer

204

(See FIGS.

11

A and

11

B). As shown, first active electrode

210

a

is attached to the distal surface of second wafer layer

202

, and a conductive strip

240

extends to via

230

to couple active electrode

210

a

to a lead wire. Similarly, wafer layers

204

and

206

(

FIGS. 11A

,

11

B,

12

A, and

12

B) each have an active electrode

210

b

,

210

c

plated to their distal surfaces, and a conductive strip

242

,

244

, respectively, extending to one of the vias

232

,

234

, respectively. Note that the vias only extend as far as necessary through the ceramic layers. As shown in

FIG. 13

, a second outer wafer layer

208

has a second return electrode

218

plated to the lateral surface

250

of layer

208

. The second return electrode

218

is coupled directly to the first return electrode

216

through a via

252

extending through the entire ceramic substrate.

Of course, it will be recognized that a variety of different types of single layer and multi-layer wafers may be constructed according to the present invention. For example,

FIGS. 14 and 15

illustrate an alternative embodiment of the multi-layer ceramic wafer, wherein the active electrodes comprise planar strips

280

that are plated or otherwise bonded between the ceramic wafer layers

282

. Each of the planar strips

280

has a different length, as shown in

FIG. 15

, so that the active electrodes can be electrically isolated from each other, and coupled to lead wires by vias (not shown).

FIG. 16

illustrates an electrosurgical probe

20

′ according to another embodiment of the present invention. Probe

20

′ generally includes handle

104

attached to shaft

100

, and has a single, thin, elongated active blade electrode

58

. Active electrode

58

is mechanically and electrically separated from return electrode

112

by a support structure

102

. The active blade electrode

58

has a sharp distal edge

59

which helps facilitate the cutting process, and sides

62

which contact the tissue (e.g., bone) as the blade electrode

58

passes through the tissue or body structure. By contacting the sides of the blade electrode

58

directly with the tissue or body structure, the electrical power supplied to electrode

58

by power supply

28

can provide hemostasis to the body structure during the cutting process. Optionally, probe

20

′ can further include one or more coagulation electrode(s) (not shown) configured to seal a severed vessel, bone, or other tissue that is being incised. Such coagulation electrode(s) may be configured such that a single voltage can be applied to coagulate with the coagulation electrode(s) while ablating tissue with the active electrode(s). According to one aspect of the invention, probe

20

′ is particularly useful for creating an incision in a patient's chest. For example, in an open-chest CABG procedure a median sternotomy is first performed in which the sternum is sectioned longitudinally so as to allow the chest to be opened for access to the thoracic cavity. Active electrodes

58

include distal edge

59

suitable for sectioning the sternum, and sides

62

suitable for arresting bone bleeding within the incised sternum. Sides

62

are configured to slidably engage the sternum as active electrode

58

is moved with respect to the sternum. Return electrode

112

is spaced proximally from active electrode

58

such that the electrical current is drawn away from the surrounding tissue. Alternatively, the return electrode

112

may be a dispersive pad located on the external surface of the patient's body. By minimizing bleeding of the sternum during an open-chest procedure, the patient's recovery time can be substantially shortened and patient suffering is alleviated.

FIGS. 17A-17C

schematically illustrate the distal portion of three different embodiments of a probe

90

according to the present invention. As shown in

FIG. 17A

, active electrodes

104

are anchored in a support

102

of suitable insulating material (e.g., ceramic or glass material, such as alumina, zirconia and the like) which could be formed at the time of manufacture in a flat, hemispherical or other shape according to the requirements of a particular procedure. In one embodiment, the support material is alumina, available from Kyocera Industrial Ceramics Corporation, Elkgrove, Ill., because of its high thermal conductivity, good electrically insulative properties, high flexural modulus, resistance to carbon tracking, biocompatibility, and high melting point. The support

102

is adhesively joined to a tubular support member

78

that extends most or all of the distance between matrix

102

and the proximal end of probe

90

. Tubular member

78

preferably comprises an electrically insulating material, such as an epoxy or silicone-based material.

According to one construction technique, active electrodes

104

extend through pre-formed openings in the support

102

so that they protrude above tissue treatment surface

212

by the desired distance. The electrodes are then bonded to the tissue treatment surface

212

of support

102

, typically by an inorganic sealing material

80

. Sealing material

80

is selected to provide effective electrical insulation, and good adhesion to both the support

102

and the platinum or titanium active electrodes. Sealing material

80

additionally should have a compatible thermal expansion coefficient, and a melting point well below that of platinum or titanium and alumina or zirconia, typically being a glass or glass ceramic.

In the embodiment shown in

FIG. 17A

, return electrode

112

comprises an annular member positioned around the exterior of shaft

100

of probe

90

. Return electrode

112

may fully or partially circumscribe tubular member

78

to form an annular gap

54

therebetween for flow of electrically conductive liquid

50

therethrough, as discussed below. Gap

54

preferably has a width in the range of 0.25 mm to 4 mm. Alternatively, probe

90

may include a plurality of longitudinal ribs between tubular member

78

and return electrode

112

to form a plurality of fluid lumens extending along the perimeter of shaft

100

. In this embodiment, the plurality of lumens will extend to a plurality of openings.

Return electrode

112

is disposed within an electrically insulative jacket

17

, which is typically formed as one or more electrically insulative sheaths or coatings, such as polytetrafluoroethylene, polyimide, and the like. The provision of the electrically insulative jacket

17

over return electrode

112

prevents direct electrical contact between return electrode

112

and any adjacent body structure. Such direct electrical contact between a body structure (e.g., the heart) and an exposed electrode member

112

could result in unwanted heating and necrosis of the structure at the point of contact.

As shown in

FIG. 17A

, return electrode

112

is not directly connected to active electrodes

104

. To complete a current path so that active electrodes

104

are electrically connected to return electrode

112

, electrically conductive liquid

50

(e.g., isotonic saline) is caused to flow along fluid path(s)

83

. Fluid path

83

is formed by annular gap

54

between outer return electrode

112

and tubular support member

78

. The electrically conductive liquid

50

flowing through fluid path

83

provides a pathway for electrical current flow between active electrodes

104

and return electrode

112

, as illustrated by the current flux lines

60

in FIG.

17

A. When a voltage difference is applied between active electrodes

104

and return electrode

112

, high electric field intensities will be generated at the distal tips of active electrodes

104

with current flow from electrodes

104

through the target tissue to the return electrode, the high electric field intensities causing ablation of tissue

52

in zone

88

.

FIG. 17B

illustrates another alternative embodiment of electrosurgical probe

90

which has a return electrode

112

positioned within tubular member

78

. Return electrode

112

may comprise a tubular member defining an inner lumen

57

for allowing electrically conductive liquid

50

(e.g., isotonic saline) to flow therethrough in electrical contact with return electrode

112

. In this embodiment, a voltage difference is applied between active electrodes

104

and return electrode

112

resulting in electrical current flow through the electrically conductive liquid

50

as shown by current flux lines

60

. As a result of the applied voltage difference and concomitant high electric field intensities at the tips of active electrodes

104

, tissue

52

becomes ablated or transected in zone

88

.

FIG. 17C

illustrates another embodiment of probe

90

that is a combination of the embodiments in

FIGS. 17A and 17B

. As shown, this probe includes both an inner lumen

57

and an outer gap or plurality of outer lumens

54

for flow of electrically conductive fluid. In this embodiment, the return electrode

112

may be positioned within tubular member

78

as in

FIG. 17B

, outside of tubular member

78

as in

FIG. 17A

, or in both locations.

FIG. 18

illustrates another embodiment of probe

90

where the distal portion of shaft

100

is bent so that active electrodes extend transversely to the shaft. Preferably, the distal portion of shaft

100

is perpendicular to the rest of the shaft so that tissue treatment surface

212

is generally parallel to the shaft axis. In this embodiment, return electrode

112

is mounted to the outer surface of shaft

100

and is covered with an electrically insulating jacket

17

. The electrically conductive fluid

50

flows along flow path

83

through return electrode

112

and exits the distal end of electrode

112

at a point proximal of tissue treatment surface

212

. The fluid is directed exterior of shaft to surface

212

to create a return current path from active electrodes

104

, through the fluid

50

, to return electrode

112

, as shown by current flux lines

60

.

FIG. 19

illustrates another embodiment of the invention where electrosurgical system

11

further includes a liquid supply instrument

64

for supplying electrically conductive fluid

50

between active electrodes

104

and a return electrode

112

′. Liquid supply instrument

64

comprises an inner tubular member or return electrode

112

′ surrounded by an electrically insulating jacket

17

. Return electrode

112

′ defines an inner passage

83

for flow of fluid

50

. As shown in

FIG. 19

, the distal portion of instrument

64

is preferably bent so that liquid

50

is discharged at an angle with respect to instrument

64

. This allows the surgical team to position liquid supply instrument

64

adjacent tissue treatment surface

212

with the proximal portion of supply instrument

64

oriented at a similar angle to probe

90

.

The present invention is not limited to an electrode array disposed on a relatively planar surface at the distal tip of probe

90

, as described above. Referring to

FIGS. 20A and 20B

, an alternative probe

90

includes a pair of electrodes

105

a

,

105

b

mounted to the distal end of shaft

100

. Electrodes

105

a

,

105

b

are electrically connected to a power supply, as described above, and preferably have tips

107

a

,

107

b

having a screwdriver shape. The screwdriver shape provides a greater amount of “edges” to electrodes

105

a

,

105

b

, to increase the electric field intensity and current density at tips

107

a

,

107

b

, thereby improving the cutting ability as well as the ability to provide hemostasis of the incised tissue.

FIG. 21

illustrates yet another embodiment designed for cutting of body tissue, organs, or structures. In this embodiment, the active electrodes

104

are arranged in a linear or columnar array of one of more closely spaced columns so that as the electrodes

104

are moved along the longer axis (denoted by arrow

160

in FIG.

21

), the current flux lines are narrowly confined at the tip of the active electrodes

104

and result in a cutting effect in the body structure being treated. As before, the current flux lines

60

emanating from the active electrodes

104

pass through the electrically conductive liquid to the return electrode structure

112

located proximal to the probe tip.

Referring now to

FIGS. 22 and 23

, alternative geometries are shown for the active electrodes

104

. These alternative electrode geometries allow the electrical current densities emanating from the active electrodes

104

to be concentrated to achieve an increased ablation rate and/or a more concentrated ablation effect due to the fact that sharper edges (i.e., regions of smaller radii of curvature) result in higher current densities.

FIG. 22

illustrates a flattened extension of a round wire active electrode

104

which results in higher current densities at the edges

180

. Another example is shown in

FIG. 23

in which the active electrode

104

is formed into a cone shaped point

182

resulting in higher current densities at the tip of the cone.

Another embodiment of the electrosurgical probe is illustrated in FIG.

24

. The electrosurgical probe

90

comprises a shaft

100

and at least two active electrodes

104

extending from a support

102

at the distal end of the shaft. The active electrodes

104

preferably define a distal edge

600

for making an incision in tissue. The edges

600

of the active electrodes

104

are substantially parallel with each other and usually spaced a distance of about 4 mm to 15 mm apart, preferably about 8 mm to 10 mm apart. The edges

600

extend from the distal end of support

102

by a distance of about 0.5 mm to 10 mm, preferably about 2 mm to 5 mm. In the exemplary embodiment, probe

90

will include a return electrode

112

spaced proximally from the active electrodes

104

. In an alternative embodiment (not shown), one of the active electrodes

104

may function as a return electrode, or the return electrode may be a dispersive pad located on an external surface of the patient's body.

FIG. 25

illustrates a distal portion of an electrosurgical probe

500

according to another embodiment of the present invention The embodiment of

FIG. 25

is particularly useful for cutting or creating incisions in tissue structures. Probe

500

comprises a support member

502

coupled to a shaft or disposable tip (not shown) as described in previous embodiments. Support member

502

preferably comprises an inorganic electrically insulating material, such as ceramic, glass or glass-ceramic. In this embodiment, however, support member

502

may comprise an organic material, such as plastic, because the active electrode

506

and return electrode

508

are both spaced away from support member

502

. Thus, the high intensity electric fields may be far enough away from support member

502

so as to allow an organic material.

An electrode assembly

504

extends from a distal end of support member

502

, preferably by a distance of about 2 mm to 20 mm. Electrode assembly

504

comprises a single, active electrode

506

and a return electrode sleeve

508

spaced proximally from active electrode

506

by an insulation member

510

, which preferably comprises an inorganic material, such as ceramic, glass or glass-ceramic. As shown, active electrode

506

preferably tapers to a sharp distal end

512

to facilitate the cutting or incising of tissue. In the exemplary embodiment, active electrode

506

has a proximal diameter of about 0.2 to 20 mm and a distal diameter of less than about 0.2 mm. Return electrode

508

is spaced from active electrode

506

a sufficient distance to prevent shorting or arcing therebetween at sufficient voltages to allow the volumetric removal of tissue. In the representative embodiment, the distal exposed portion of return electrode

508

is spaced about 0.5 to about 5 mm from the proximal exposed portion of active electrode

506

. Of course, it will be recognized that the present invention is not limited to the particular dimensions and configuration of the electrode assembly

504

described herein, and a variety of different configurations may be envisioned depending on the surgical application.

As shown, probe

500

includes a fluid lumen

520

passing through support member

502

to a distal opening (not shown) at the distal end of support member

502

. Fluid lumen

520

is coupled to a supply of electrically conductive fluid, such as isotonic saline, or other suitable conductive fluid for delivery of such fluid to the target site. In the exemplary embodiment, probe

500

is designed such that lumen

520

will be positioned above electrode assembly

504

during use such that the conductive fluid exiting the distal opening of lumen

520

will naturally pass over return electrode

508

and active electrode

506

thereby creating a current path therebetween. In addition, the conductive fluid will be sufficient to cover the active electrode

506

such that the conditions for plasma formation can be met, as described in detail above.

FIGS. 26

, and

27

A-C illustrate another exemplary electrosurgical probe

310

for cutting, incising, or removing tissue structures. Probe

310

comprises a shaft or disposable tip

313

removably coupled to a proximal handle

312

, and an electrically insulating electrode support member

370

extending from tip

313

for supporting a plurality of active electrodes

358

. Tip

313

and handle

312

typically comprise a plastic material that is easily molded into a suitable shape for handling by the surgeon. As shown in

FIGS. 27A and 27B

, handle

312

defines an inner cavity

372

that houses the electrical connections

374

, and provides a suitable interface for connection to electrical connecting cable

34

(see FIG.

1

). In the exemplary embodiment, handle

312

is constructed of a steam autoclavable plastic or metal (e.g., polyethylether ketone, or a stable metal alloy containing aluminum and/or zince) so that it can be re-used by sterilizing handle

312

between surgical procedures. High service temperature materials are preferred, such as a silicone cable jacket and a poly-ether-imide handpiece or ULTEM® that can withstand repeated exposure to high temperatures.

Referring to

FIGS. 27A-27C

, tip

313

preferably comprises first and second housing halves

500

,

502

that snap fit together, and form a recess

404

therebetween for holding electrode support member

370

within the tip

313

. Electrode support member

370

extends from the distal end of tip

313

, usually by about 0.5 mm to 20 mm, and provides support for a plurality of electrically isolated active electrodes

358

and one or more return electrodes

400

. Alternatively, electrode support member

370

may be recessed from the distal end of tip

313

to help confine the electrically conductive fluid around the active electrodes

358

during the surgical procedure, as discussed above. Electrode support member

370

has a substantially planar tissue treatment surface

380

that is usually disposed at an angle of about 10 to 90 degrees relative to the longitudinal axis of handle

312

to facilitate handling by the surgeon. In the exemplary embodiment, this function is accomplished by orienting tip

313

at an acute angle relative to the longitudinal axis of handle

312

.

In the embodiment shown in

FIGS. 26-27C

, probe

310

includes a single annular return electrode

400

for completing the current path between active electrodes

358

and power supply

28

(see FIG.

1

). As shown, return electrode

400

preferably has a fluid contact surface slightly proximal to tissue treatment surface

380

, typically by about 0.1 mm to 2 mm, and preferably by about 0.2 mm to 1 mm. Return electrode

400

is coupled to a connector

404

that extends to the proximal end of handle

313

, where it is suitably connected to power supply

28

(FIG.

1

).

Referring again to

FIGS. 27A-27C

, tip

313

further includes a proximal hub

506

for supporting a male electrical connector

508

that holds a plurality of wires

510

each coupled to one of the active electrodes

358

or to return electrode

400

on support member

370

. A female connector

520

housed within handle

312

is removably coupled to male connector

508

, and a plurality of wires

522

extend from female connector

520

through a strain relief

524

to cable

334

. Both sets of wires

510

,

522

are insulated to prevent shorting in the event of fluid ingress into the probe

310

. This design allows for removable connection of the electrodes in tip

313

with the connector

520

within handle

312

so that the handle can be re-used with different tips

313

. Probe

310

will preferably also include an identification element, such as a coded resistor (not shown), for programming a particular voltage output range and mode of operation for the power supply. This allows the power supply to be employed with a variety of different probes for a variety of different applications.

In the representative embodiment, probe

310

includes a fluid tube

410

(

FIG. 26

) for delivering electrically conductive fluid to the target site. Fluid tube

410

is sized to extend through a groove

414

in handle

313

and through an inner cavity

412

in tip

312

to a distal opening

414

(

FIG. 26

) located adjacent electrode support member

370

. Tube

410

extends all the way through inner cavity

412

to opening

414

to eliminate any possible fluid ingress into cavity

412

. Fluid tube

410

includes a proximal connector for coupling to an electrically conductive fluid source

321

.

Probe

310

will also include a valve or equivalent structure for controlling the flow rate of the electrically conductive fluid to the target site. In the representative embodiment shown in

FIGS. 27A-27C

, handle

312

comprises a main body

422

coupled between distal hub

418

and strain relief

420

, and a rotatable sleeve

416

around main body

422

. Distal hub

418

has an opening

419

for receiving proximal hub

506

of tip

313

for removably coupling the tip

313

to the handle

312

. Sleeve

416

is rotatably coupled to strain relief

420

and distal hub

418

to provide a valve structure for fluid tube

410

. As shown in

FIG. 27A

, fluid tube

410

extends through groove

414

from strain relief

420

, through main body

422

and distal hub

420

to tip

313

. Rotation of sleeve

416

will impede, and eventually obstruct, the flow of fluid through tube

410

. Of course, this fluid control may be provided by a variety of other input and valve devices, such as switches, buttons, etc.

In alternative embodiments, the fluid path may be directly formed in probe

310

by, for example, a central inner lumen or an annular gap (not shown) within the handle and the tip. This inner lumen may be formed near the perimeter of the probe

310

such that the electrically conductive fluid tends to flow radially inward towards the target site, or it may be formed towards the center of probe

310

so that the fluid flows radially outward. In addition, the electrically conductive fluid may be delivered from a fluid delivery element (not shown) that is separate from probe

310

. In arthroscopic surgery, for example, the body cavity will be flooded with isotonic saline and the probe

310

will be introduced into this flooded cavity. Electrically conductive fluid will be continually resupplied to maintain the conduction path between return electrode

400

and active electrodes

358

. A more complete description of alternative electrosurgical probes incorporating one or more fluid lumen(s) can be found in commonly assigned, co-pending application Ser. No. 08/485,219, filed on Jun. 7, 1995, the complete disclosure of which is incorporated herein by reference.

Referring now to

FIG. 26

, electrically isolated active electrodes

358

are spaced apart over tissue treatment surface

380

of electrode support member

370

, preferably in a linear array. In the representative embodiment, three active electrodes

358

, each having a substantially conical shape, are arranged in a linear array extending distally from surface

380

. Active electrodes

358

will usually extend a distance of about 0.5 mm to 20 mm from tissue treatment surface

380

, preferably about 1 mm to 5 mm. Applicant has found that this configuration increases the electric field intensities and associated current densities at the distal edges of active electrodes

358

, which increases the rate of tissue cutting. In the representative embodiment, the tissue treatment surface

380

has a circular cross-sectional shape with a diameter in the range of about 0.5 mm to 20 mm (preferably about 2 mm to 10 mm). The individual active electrodes

358

preferably taper outward as shown, or they may form a distal edge, such as the electrodes shown in

FIGS. 3 and 24

.

Probe

430

of

FIG. 28

includes a shaft

432

coupled to a proximal handle

434

for holding and controlling shaft

432

. Probe

430

includes an active electrode array

436

at the distal tip of shaft

432

, an annular return electrode

438

extending through shaft

432

and proximally recessed from the active electrode array

436

, and an annular lumen

442

between return electrode

438

and an outer insulating sheath

446

. Probe

430

further includes a liquid supply conduit

444

attached to handle

434

and in fluid communication with lumen

442

, and a source of electrically conductive fluid (not shown) for delivering the fluid past return electrode

438

to the target site on the tissue

440

. Electrode array

436

is preferably flush with the distal end of shaft

432

or distally extended from the distal end by a small distance (on the order of 0.005 inches) so as to minimize the depth of ablation. Preferably, the distal end of shaft

432

is beveled to improve access and control of probe

430

while treating the target tissue.

Yet another embodiment of the present invention is shown in FIG.

29

. Auxiliary active electrodes

458

,

459

are positioned at the distal tip

70

of the probe. Auxiliary active electrodes

458

,

459

may be the same size as ablation active electrodes

58

, or larger as shown in FIG.

29

. One operating arrangement is to connect auxiliary active electrodes

458

,

459

to two poles of a high frequency power supply to form a bipolar circuit allowing current to flow between the terminals of auxiliary active electrodes

458

,

459

as shown by current flux lines

460

. Auxiliary active electrodes

458

,

459

are electrically isolated from ablation electrodes

58

. By proper selection of the inter-electrode spacing, W

2

, and electrode width, W

3

, and the frequency of the applied voltage, the current flux lines

460

can be caused to flow below the target layer as described above.

The voltage will preferably be sufficient to establish high electric field intensities between the active electrode array

436

and the target tissue

440

to thereby induce molecular breakdown or disintegration of several cell layers of the target tissue. As described above, a sufficient voltage will be applied to develop a thin layer of vapor within the electrically conductive fluid and to ionize the vaporized layer or region between the active electrode(s) and the target tissue. Energy in the form of charged particles are discharged from the vapor layer to ablate the target tissue, thereby minimizing necrosis of surrounding tissue and underlying cell layers.

With reference to

FIG. 30

, there is shown in perspective view an electrosurgical probe

700

, according to another embodiment of the invention. Probe

700

includes a shaft

702

having a shaft distal end portion

702

a

and a shaft proximal end portion

702

b

. Shaft

702

is affixed at its proximal end

702

b

to a handle

704

. Shaft

702

typically comprises an electrically conductive material, usually a metal, such as tungsten, stainless steel, platinum or its alloys, titanium or its alloys, molybdenum or its alloys, nickel or its alloys. An electrically insulating electrode support

710

is disposed at shaft distal end

702

a

. An active electrode

712

is disposed on electrode support

710

. Active electrode

712

comprises a blade electrode (e.g.,

FIGS. 31A

,

31

B). An electrically insulating sleeve

716

covers a portion of shaft

702

, and terminates at sleeve distal end

716

a

to define an exposed portion of shaft

702

extending between electrode support proximal end

710

b

and sleeve distal end

716

a

. This exposed portion of shaft

702

defines a return electrode

718

on shaft distal end portion

702

a

. (In an alternative embodiment, the return electrode may take the form of an annular band of an electrically conductive material, e.g., a platinum alloy, disposed on the exterior of the shaft distal end.) A cavity within handle

704

accommodates a connection block

706

which is connected to active electrode

712

and return electrode

718

via electrode leads (not shown). Connection block

706

provides a convenient mechanism for coupling active electrode

712

and return electrode

718

to opposite poles of a power supply (e.g., power supply

28

, FIG.

1

).

FIG. 31A

is a perspective view of an active electrode

712

of probe

700

, according to one embodiment of the invention. Active electrode

712

is in the form of a single blade electrode which extends from electrode support

710

to a distance, H

b

. The distance H

b

may vary, for example, according to the intended applications of probe

700

, and the value of H

b

is at least to some extent a matter of design choice. Typically, for a broad array of electrosurgical procedures, the distance H

b

is in the range of from about 0.02 mm to about 5 mm. Active electrode

712

includes an active edge

713

which is adapted for generating high current densities thereat upon application of a high frequency voltage from the power supply between active electrode

712

and return electrode

718

. In this way, active edge

713

can efficiently effect localized ablation of tissues via molecular dissociation of tissue components which contact, or are in close proximity to, active edge

713

. A process for ablation of tissues via molecular dissociation of tissue components has been described hereinabove.

As best seen in

FIG. 31B

, the blade-like active electrode

712

further includes first and second blade sides,

714

a

,

714

b

, respectively. First and second blade sides

714

a

,

714

b

are separated by a maximum distance, W

b

. The distance W

b

is typically in the range of from about 0.1 mm to about 2.5 mm. In the embodiment of

FIG. 31B

, first and second blade sides

714

a

,

714

b

are substantially parallel to each other. Each of first and second blade sides

714

a

,

714

b

are adapted for engaging tissue severed, ablated, or otherwise modified by active edge

713

, and for coagulating tissue engaged by first blade side

714

a

and/or second blade side

714

b

. In this way, active electrode

712

can precisely and effectively sever, ablate, or otherwise modify a target tissue with active edge

713

to form a first-modified tissue, and at the same time, or shortly thereafter, further modify the first-modified tissue by means of first and second blade sides

714

a

,

714

b

. For example, active edge

713

can make an incision in a target tissue via localized molecular dissociation of target tissue components, while first and second blade sides

714

a

,

714

b

can effect hemostasis in the severed tissue.

FIGS. 32A

,

32

B, and

32

C are a side view, a plan view, and an end view, respectively, of electrosurgical probe

700

having a blade-like active electrode

712

, according to one embodiment of the invention. In the embodiment of

FIGS. 32A-C

, electrode support

710

is disposed at the terminus of shaft

702

, and active electrode

712

is affixed to support distal end

710

a

(e.g., FIG.

33

A). However, other arrangements for electrode support

710

and active electrode

712

are within the scope of the invention (e.g.,

FIGS. 34A-C

,

35

A-C). Active electrode

712

is in the form of a substantially flat metal blade. Active electrode

712

is shown as being substantially rectangular as seen from the side (FIG.

32

A). However, various other shapes for active electrode

712

are within the scope of the invention (e.g., FIGS.

33

C-E).

FIG. 32C

is an end view of probe

700

as seen along the lines

32

C—

32

C of

FIG. 32B

, showing a laterally compressed region

703

of shaft

702

. Laterally compressed region

703

may be adapted for housing electrode support

710

. Laterally compressed region

703

may also facilitate manipulation of shaft distal end portion

702

a

of probe

700

during various surgical procedures, particularly in situations where accessibility of a target tissue is restricted.

FIGS. 33A and 33B

are a side view and a plan view, respectively, of the distal end of probe

700

, showing details of shaft distal end portion

702

a

and terminally disposed blade active electrode

712

, according to one embodiment of the invention. Blade electrode

712

is substantially rectangular in shape as seen from the side (FIG.

33

A). The distal end of shaft

702

includes laterally compressed region

703

. As seen from the side (FIG.

33

A), laterally compressed region

703

appears wider than more proximal portions of shaft

702

.

FIG. 33B

is a plan view of probe

700

as seen along the lines

33

B—

33

B of

FIG. 33A

, in which laterally compressed region

703

appears narrower than more proximal portions of shaft

702

. Electrode support

710

is mounted to the distal end of laterally compressed region

703

. Typically, electrode support

710

comprises a durable, electrically insulating, refractory material having a certain amount of flexibility. For example, electrode support

710

may comprise a material such as a silicone rubber, a polyimide, a fluoropolymer, a ceramic, or a glass.

FIGS. 33C-33E

each show a side view of the distal end of probe

700

having a terminal blade active electrode

712

, according to three different embodiments of the invention. Electrode support

710

is mounted terminally on shaft

702

, and includes a support distal end

710

a

and a support proximal end

710

b

. In the embodiment of

FIG. 33C

, active edge

713

of active electrode

712

is arcuate, convex, or substantially semi-circular in shape. In the embodiment of

FIG. 33D

, active electrode

712

has a pointed active edge

713

, while in the embodiment of

FIG. 33E

, the active edge

713

of active electrode

712

is serrated.

FIG. 34A

shows in side view an electrosurgical probe

700

having electrode support

710

mounted terminally on shaft

702

and blade active electrode

712

disposed laterally on electrode support

710

, according to another embodiment of the invention.

FIG. 34B

is a plan view of probe

700

taken along the lines

34

B—

34

B of FIG.

34

A.

FIG. 34C

is an end view taken along the lines

34

C—

34

C of FIG.

34

A. In the embodiments of

FIGS. 34A-C

, electrode

712

is in the form a substantially flat, metal blade having first and second blade sides

714

a

,

714

b

, substantially parallel to each other. First and second blade sides

714

a

,

714

b

are adapted for engaging and coagulating severed or modified tissue, as described hereinabove.

FIG. 35A

shows in side view an electrosurgical probe

700

having electrode support

710

mounted laterally on the distal end of shaft

702

, according to another embodiment of the invention. Blade active electrode

712

is mounted laterally on electrode support

710

.

FIG. 35B

is a plan view of probe

700

taken along the lines

35

B—

35

B of FIG.

35

A.

FIG. 35C

is an end view taken along the lines

35

C—

35

C of FIG.

35

A. Active electrode

712

is in the form a substantially flat, metal blade having first and second blade sides

714

a

,

714

b

, substantially parallel to each other. Electrode support

710

is mounted laterally on laterally compressed region

703

of shaft

702

.

FIG. 36A

shows a side view of the distal end of an electrosurgical probe

700

, wherein shaft

702

includes a beveled end

728

to which electrode support

710

is mounted. Blade active electrode

712

is disposed on electrode support

710

. The arrangement of electrode support

710

and electrode

712

on beveled end

728

may facilitate access of shaft distal end portion

702

a

in general, and of electrode

712

in particular, to a target tissue during various surgical procedures, particularly in situations where accessibility is restricted.

FIG. 36B

shows a side view of the distal end of an electrosurgical probe

700

, according to another embodiment of the invention. Shaft

702

includes a curved distal end

702

a′

. Electrode support

710

is mounted on distal end

702

a′

, and blade active electrode

712

is affixed to electrode support

710

. Curved distal end

702

a′

facilitates access of electrode

712

to a target tissue during various surgical procedures.

Although in the embodiments of

FIGS. 34A-C

,

35

A-C, and

36

A-B active electrode

712

is shown as being substantially rectangular, this representation should not be construed as limiting these embodiments to a rectangular active electrode

712

. Indeed, each of the embodiments of

FIGS. 34A-C

,

35

A-C, and

36

A-B may have an active electrode

712

in a broad range of shapes, including those represented in

FIGS. 33C-E

.

FIG. 37A

shows in side view an electrosurgical probe

700

having an exterior tube

724

arranged on shaft

702

and coupled at its proximal end to a connection tube

720

at handle

704

. Exterior tube

724

may comprise a plastic tube of suitable length commensurate with the size of probe

700

. Exterior tube

724

defines a lumen

726

, and typically terminates at shaft distal end

702

a

at a location somewhat proximal to electrode support

710

. In some embodiments, probe

700

may include two or more exterior tubes

724

, each exterior tube

724

having lumen

726

. Each lumen

726

may serve as a conduit for an aspiration stream, or as a conduit for delivery of an electrically conductive fluid to the shaft distal end, generally as described hereinabove.

FIG. 37B

is an end view of probe

700

taken along the lines

37

B—

37

B of

FIG. 37A

, showing exterior tube

724

and lumen

726

in relation to shaft

702

. The diameter of exterior tube

724

is, at least to some extent, a matter of design choice. Exterior tube

724

may comprise a substantially rigid or somewhat flexible plastic tube comprising polyethylene, a polyimide, a fluoropolymer, and the like.

FIG. 38A

shows, in side view, an electrosurgical probe

700

having an outer sheath

722

surrounding the exterior of a portion of shaft

702

, according to another embodiment of the invention. Outer sheath

722

is coupled at its proximal end to a connection tube

720

at handle

704

. Outer sheath

722

may comprise a plastic tube of suitable length and having a diameter larger than that of shaft

702

. Together with the exterior of shaft

702

, outer sheath

722

defines a lumen

726

′ in the form of an annular void. Typically, outer sheath

722

terminates at shaft distal end

702

a

at a location proximal to electrode support

710

. Lumen

726

′ typically serves as a conduit for delivery of an electrically conductive fluid to the shaft distal end.

FIG. 38B

is an end view of probe

700

taken along the lines

38

B—

38

B of

FIG. 38A

, showing outer sheath

722

and lumen

726

′ in relation to shaft

702

. The diameter of outer sheath

722

is, at least to some extent, a matter of design choice. Outer sheath

722

may comprise a substantially rigid or somewhat flexible plastic tube comprising polyethylene, a polyimide, and the like.

FIG. 39A

schematically represents an electrosurgical probe

700

, according to another embodiment of the invention. Probe

700

includes shaft

702

and handle

704

affixed at shaft proximal end

702

b

. A first electrode support

711

a

and a second electrode support

711

b

are disposed at shaft proximal end

702

a

. A blade active electrode

712

is arranged on first and second electrode supports,

711

a

,

711

b

. Each of first and second electrode supports

711

a

,

711

b

may comprise a refractory and electrically insulating material, such as a silicone rubber or the like, as described hereinabove. A return electrode

718

is located at shaft distal end

702

proximal to first and second electrode supports

711

a

,

711

b

. Return electrode

718

may comprise an exposed portion of shaft distal end

702

a

(e.g., FIGS.

32

A-C). Blade active electrode

712

typically extends distally from electrode support

710

by a distance in the range of from about 0.1 mm to about 10 mm, an more typically from about 2 mm to 10 mm.

Blade active electrode

712

and return electrode

718

may be independently coupled to opposite poles of a high frequency power supply via electrode leads (not shown) and a connection block (e.g., FIG.

30

). In one embodiment, an active electrode lead is coupled to one of first and second electrode arms

715

a

,

715

b

, and the other arm terminates in a free, electrically isolated end, for example, within first electrode support

711

a

or second electrode support

711

b

. Blade active electrode

712

includes a crosspiece

715

c

(

FIGS. 39B-D

) located distal to aspiration port

734

. A fluid delivery element or unit including an outer sheath

722

′ (e.g.,

FIG. 39B

) is omitted from

FIG. 39A

for the sake of clarity.

FIG. 39B

is a partial sectional view of probe

700

of

FIG. 39A

as seen from the side. Outer sheath

722

′ defines an annular fluid delivery lumen

726

′ between sheath

722

′ and shaft

702

. Lumen

726

′ terminates in an annular fluid delivery port

725

at shaft distal end

702

a

. Fluid delivery lumen

726

′ is in communication proximally with a fluid delivery tube

721

. Solid arrows indicate the direction of flow of an electrically conductive fluid (e.g., isotonic saline) within fluid delivery lumen

726

′. Aspiration port

734

is in communication proximally with an aspiration lumen

732

and an aspiration tube

730

. Solid arrows within aspiration lumen

732

indicate the direction of flow of an aspiration stream, which flows from aspiration port

734

towards a source of vacuum (not shown), the latter coupled to aspiration tube

730

.

FIG. 39C

is an end view of probe

700

taken along the lines

39

C—

39

C of FIG.

39

B. Active electrode

712

includes crosspiece

715

c

extending between first and second electrode arms

715

a

,

715

b

, respectively (FIG.

39

D). Active electrode

712

further includes first and second blade sides

714

a

,

714

b

. In some embodiments, first and second blade sides

714

a

,

714

b

are adapted for engaging tissue that has been severed, and for coagulating the severed tissue. Crosspiece

715

c

at least partially spans aspiration port

734

. Typically, active electrode

712

comprises a single metal blade, comprising a material such as platinum, tungsten, palladium, iridium, or titanium, or their alloys.

FIG. 39D

shows detail of the distal portion of probe

700

of

FIGS. 39A-C

including blade active electrode

712

. As shown, first and second electrode arms

715

a

,

715

b

are disposed on first and second electrode supports

711

a

,

711

b

, respectively. In an alternative embodiment, first and second electrode arms

715

a

,

715

b

may be disposed on a single annular electrode support having a substantially central void defining aspiration port

734

. In one embodiment, active electrode

712

includes both a distal active edge

713

a

, and a proximal active edge

713

b

. Distal active edge

713

a

, in particular, is adapted for aggressively ablating tissue via molecular dissociation of tissue components and for severing tissue targeted for resection, transection, dissection, or other treatment.

FIG. 40A

is a partial sectional view of an electrosurgical probe

700

according to another embodiment of the invention. Probe

700

of

FIG. 40A

generally includes shaft

702

and handle

704

, together with a fluid delivery element, and an aspiration unit, essentially as for the embodiment described with reference to

FIGS. 39A-D

. In the interests of brevity these elements and features will not described in detail with reference to

FIGS. 40A-C

. The embodiment of

FIG. 40A

differs from other embodiments described herein in having an active electrode in the form of a plasma hook

712

′. Hook

712

′ is in some respects analogous to plasma blade electrodes described hereinabove. For example, in one respect hook

712

′ is analogous to a truncated version of electrode

712

of the embodiment of

FIGS. 39A-D

in which one of arms

715

a

or

715

b

is omitted leaving one electrode arm affixed to crosspiece

715

c

. From a functional standpoint, hook

712

′ allows the operator (surgeon) to ablate tissue by drawing the instrument towards himself/herself. In this manner, greater control is exerted over the amount or extent of tissue removed or severed by probe

700

. Hook

712

′ includes a first axial portion

712

′

a

(

FIG. 40C

) in contact at its proximal end with electrode support

710

. Hook

712

′ may further include a second portion

712

′

b

extending from the distal portion of first axial portion

712

′

a

. In some embodiments, second portion

712

′

b

is arranged substantially orthogonal to first axial portion

712

′

a

. In one embodiment, second portion

712

′

b

may be structurally similar or analogous to crosspiece

715

c

of the embodiment of

FIGS. 39A-D

. Second portion

712

′

b

at least partially spans aspiration port

734

(FIG.

40

B). Electrode support

710

may comprise a refractory and electrically insulating material, such as a silicone rubber or the like, as described hereinabove.

FIG. 40B

shows an end view of probe

700

taken along the lines

40

B—

40

B of FIG.

40

A. Hook

712

′ includes first and second blade sides

714

a

,

714

b

. Second portion

712

′

b

extends at least partially across aspiration port

734

.

FIG. 40C

shows detail of the distal end portion of probe

700

of

FIGS. 40A

,

40

B, including hook

712

′. Hook

712

′ includes a distal active edge

713

a

, a proximal active edge

713

b

, and an active tip

713

c

. Return electrode

718

is located proximal to electrode support

710

. Upon application of a high frequency voltage between hook

712

′ and return electrode

718

, a high current density may be generated at each of distal active edge

713

a

, proximal active edge

713

b

, and active tip

713

c

. Each of distal active edge

713

a

, proximal active edge

713

b

, and active tip

713

c

may be adapted for severing tissue via electrosurgical molecular dissociation of tissue components.

FIGS. 41A

,

41

B, and

41

C each show detail of the distal end portion of an electrosurgical probe including a hook electrode

712

′, according to three different embodiments of the invention. In the embodiment of

FIG. 41A

, hook

712

′ is curved, having a convex distal edge

713

a

, and a concave proximal edge

713

b

. In the embodiment of

FIG. 41B

, proximal edge

713

b

includes serrations thereon. In an alternative embodiment (not shown), distal edge

713

a

, and/or active tip

713

c

may be similarly serrated. In the embodiment of

FIG. 41C

, hook

712

′ is curved, having a concave distal edge

713

a

, and a convex proximal edge

713

b

. According to various embodiments of probe

700

, second portion

712

′

b

may have a length which is less than, equal to, or greater than the diameter of shaft

702

. In the latter case, second portion

712

′

b

extends laterally beyond the exterior surface of shaft

702

(e.g., FIG.

41

C). In each of the embodiments of

FIGS. 41A-C

, hook

712

′ typically comprises a single blade having first and second blade sides

714

a

,

714

b

(e.g., FIG.

40

B). Hook

712

′ typically comprises a metal such as platinum, tungsten, palladium, iridium, or titanium, or their alloys.

FIGS. 42A-B

schematically represent a process during treatment of a patient with electrosurgical probe

700

. Blade active electrode

712

is affixed to support

710

on shaft

702

. Blade active electrode

712

includes active edge

713

and first and second blade sides,

714

a

,

714

b

(e.g., FIGS.

31

A-B). Referring to

FIG. 42A

, active edge

713

forms an incision, I, in a target tissue, T, via localized molecular dissociation of tissue components upon application of a high frequency voltage between active electrode

712

and return electrode

718

. (The localized molecular dissociation may be facilitated by the delivery of a suitable quantity of an electrically conductive fluid (e.g. isotonic saline) to form a current flow path between active electrode

712

and return electrode

718

.) With reference to

FIG. 42B

, as the incision I is deepened within tissue T, first and second blade sides,

714

a

,

714

b

engage severed tissue in regions indicated by the arrows labeled E. In this way, the severed tissue is coagulated by first and second blade sides,

714

a

,

714

b

, thereby effecting hemostasis at the point of incision of the tissue.

FIG. 43A

schematically represents a number of steps involved in a method of treating a patient with an electrosurgical probe, wherein step

1000

involves positioning the distal end of the probe adjacent to target tissue such that an active electrode of the probe is in contact with or in close proximity to the target tissue. In one embodiment, the active electrode is spaced a short distance from the target tissue, as described hereinabove. Typically, step

1000

involves positioning the probe such that an active edge of the active electrode makes contact with, or is in close proximity to, the target tissue. Step

1002

involves delivering an electrically conductive fluid to the distal end of the probe in the vicinity of the active electrode and the return electrode, such that the electrically conductive fluid forms a current flow path between the active electrode and the return electrode. The electrically conductive fluid may be delivered via an exterior tube disposed on the outside of the shaft (e.g.,

FIGS. 37A

,

37

B), or an outer sheath external to the shaft and forming an annular fluid delivery lumen (e.g.,

FIGS. 38A

,

38

B). The electrically conductive fluid may be a liquid, a gel, or a gas. Apart from providing an efficient current flow path between the active and return electrodes, a clear, colorless electrically conductive liquid, such as isotonic saline, exhibits the added advantage of increasing the visibility of the surgeon at the target site. However, in situations where there is an abundance of electrically conductive body fluids (e.g., blood, synovial fluid) already present at the target site, step

1002

may optionally be omitted.

Step

1004

involves applying a high frequency voltage between the active electrode and the return electrode sufficient to ablate or otherwise modify the target tissue via localized molecular dissociation of target tissue components. By delivering an appropriate high frequency voltage to a suitably configured probe, the target tissue can be incised, dissected, transected, contracted, or otherwise modified. In addition, the modified tissue can also be coagulated (e.g., FIG.

42

B). The frequency of the applied voltage will generally be within the ranges cited hereinabove. For example, the frequency will typically range from about 5 kHz to 20 MHz, usually from about 30 kHz to 2.5 MHz, and often between about 100 kHz and 200 kHz. The root mean square (RMS) voltage that is applied in step

1004

is generally in the range of from about 5 volts to 1000 volts RMS, more typically being in the range of from about 10 volts to 500 volts RMS. The actual voltage applied may depend on a number of factors, including the size of the active electrode, the operating frequency, and the particular procedure or desired type of modification of the tissue (incision, contraction, etc.), as described hereinabove.

Step

1006

involves manipulating the probe with respect to the tissue at the target site. For example, the probe may be manipulated such that an active edge of a blade or hook electrode reciprocates with respect to the target tissue, such that the target tissue is severed, incised, or transected at the point of movement of the active edge by a process involving molecular dissociation of tissue components. In embodiments where the active electrode is in the form of a hook, step

1006

may involve engaging the hook against the target tissue and drawing the hook towards the operator in order to cut or sever the tissue. In this manner, the extent of cutting or severing can be precisely controlled. In one embodiment, step

1006

involves reciprocating an active edge in a direction parallel to a surface of the target tissue. Typically, step

1006

is performed concurrently with step

1004

. Step

1002

may be performed at any stage during the procedure, and the rate of delivery of the electrically conductive fluid may be regulated by a suitable mechanism, such as a valve.

Step

1008

involves modifying the target tissue as a result of the high frequency voltage applied in step

1004

. The target tissue may be modified in a variety of different ways, as referred to hereinabove. The type of tissue modification achieved depends, inter alia, on the voltage parameters of step

1004

; the shape, size, and composition of the active electrode; and the manner in which the probe is manipulated by the surgeon in step

1006

. At relatively high voltage levels, tissue components typically undergo localized molecular dissociation, whereby the target tissue can be dissected, incised, transected, etc. At a lower voltage, or at a lower current density on the active electrode surface, the target tissue can be contracted (e.g., by shrinkage of collagen fibers in the tissue), or a blood vessel can be coagulated. For example, in step

1010

the first and second blade sides of the active electrode may be engaged against a region of the target tissue which has been modified as a result of localized molecular dissociation of tissue components in step

1008

. The first and second blade sides are substantially flat metal plates having lower current densities than the active edge. In this manner, the lower current densities of the first and second blade sides cause further modification (e.g., coagulation) of the previously modified (e.g., severed) target tissue (step

1012

).

FIG. 43B

schematically represents a number of steps involved in a method of severing tissue with an electrosurgical probe via a process involving molecular dissociation of tissue components, and of coagulating the severed tissue with the same electrosurgical probe during a single procedure, according to one embodiment of the invention. The electrosurgical probe typically comprises an active electrode in the form of a single, substantially flat metal hook or blade having at least one active edge adapted for electrosurgically severing the tissue, and first and second blade sides adapted for effecting hemostasis of the severed tissue. Steps

1000

′ through

1006

′ are substantially the same or analogous to steps

1000

through

1006

, as described hereinabove with reference to FIG.

43

A. Step

1008

′ involves severing the target tissue via localized molecular dissociation of tissue components due to high current densities generated at the position of an active edge upon execution of step

1004

′. Step

1010

′ involves engaging the first and second blade sides against the tissue severed in step

1008

′, whereby blood/blood vessels in the severed tissue are coagulated as a result of the relatively low current densities on the first and second blade sides (step

1012

′).

FIG. 44

schematically represents a number of steps involved in a method of dissecting a tissue or organ of a patient with an electrosurgical probe having a hook or blade active electrode, according to one embodiment of the invention, wherein step

1100

involves accessing an organ or tissue. Typically, accessing an organ or tissue in step

1100

involves incising an overlying tissue which conceals the organ or tissue to be dissected. As an example, in an open chest procedure involving a median sternotomy, the thoracic cavity is accessed by making a longitudinal incision though the sternum. Incising an overlying tissue in step

1100

may be performed generally according to the methods described with reference to

FIG. 43A

or

43

B. Step

1102

involves positioning the distal end of the electrosurgical probe, and in particular an active edge of the hook or blade active electrode, in at least close proximity to connective tissue adjacent to the tissue or organ to be dissected. As an example, the connective tissue may be soft tissue, such as adipose tissue, or relatively hard tissue such as cartilage or bone. Optional step

1104

involves delivering an electrically conductive fluid to the distal end of the probe such that the electrically conductive fluid forms a current flow path between the active electrode and the return electrode, generally as described for step

1002

, supra. Step

1106

involves applying a high frequency voltage between the active electrode and the return electrode, generally as described for step

1004

, supra.

Depending on the type of procedure, e.g., the nature of the tissue or organ to be dissected, optional step

1108

may be performed, in which the probe is manipulated such that an active edge of the active electrode is moved with respect to the connective tissue adjacent to the tissue or organ to be dissected. Where the active electrode comprises a hook, the hook may be engaged against the connective tissue and drawn towards the operator of the probe to precisely control the degree of cutting or tissue removal. Step

1110

involves electrosurgically ablating, via molecular dissociation of connective tissue components, at least a portion of the connective tissue adjacent to the tissue or organ to be dissected. As an example, connective tissue adjacent to the internal mammary artery may be dissected by a process involving molecular dissociation of connective tissue components, in either an open-chest or a minimally invasive procedure, such that the IMA is substantially free from connective tissue over a portion of its length.

It is to be understood that the electrosurgical apparatus of the invention, e.g., probe

700

, is by no means limited to those methods described with reference to

FIGS. 42A-44

. Thus, as stated hereinabove, embodiments of an electrosurgical probe having an active electrode in the form of a blade or hook are applicable to a broad range of surgical procedures, such as ablation, incision, contraction, coagulation, or other modification of: connective tissue, including adipose tissue, cartilage, and bone; dermal tissue; vascular tissues and organs, including arteries and veins; and tissues of the shoulder, knee, and other joints. Thus, while the exemplary embodiments of the present invention have been described in detail, by way of example and for clarity of understanding, a variety of changes, adaptations, and modifications will be apparent to those of skill in the art. Therefore, the scope of the present invention is limited solely by the appended claims.

Number	Date	Country
3930451	Mar 1991	DE
0 703 461	Mar 1996	EP
0 740 926	Nov 1996	EP
0 754 437	Jan 1997	EP
0 623 316	Mar 1999	EP
0 717 966	Apr 2003	EP
2313949	Jan 1977	FR
2 308 979	Jul 1997	GB
2 308 980	Jul 1997	GB
2 308 981	Jul 1997	GB
2 327 350	Jan 1999	GB
2 327 351	Jan 1999	GB
2 327 352	Jan 1999	GB
2 379 878	Mar 2003	GB
57-57802	Apr 1982	JP
57-117843	Jul 1982	JP
9003152	Apr 1990	WO
WO 9007303	Jul 1990	WO
9221278	Dec 1992	WO
WO 9313816	Jul 1993	WO
9320747	Oct 1993	WO
WO 9404220	Mar 1994	WO
9408654	Apr 1994	WO
WO9534259	Dec 1995	WO
9600042	Jan 1996	WO
9700646	Jan 1997	WO
9700647	Jan 1997	WO
9724073	Jul 1997	WO
WO 9724074	Jul 1997	WO
9724993	Jul 1997	WO
9724994	Jul 1997	WO
9748345	Dec 1997	WO
9748346	Dec 1997	WO
9827879	Jul 1998	WO
9827880	Jul 1998	WO
9807468	Feb 1999	WO
9951155	Oct 1999	WO
9951158	Oct 1999	WO
0 324 339	Mar 2003	WO

	Number	Date	Country
Parent	09/162117	Sep 1998	US
Child	09/780745		US
Parent	09/041934	Mar 1998	US
Child	09/162117		US
Parent	08/977845	Nov 1997	US
Child	09/041934		US
Parent	08/562332	Nov 1995	US
Child	08/977845		US
Parent	08/485219	Jun 1995	US
Child	08/562332		US

Bladed electrosurgical probe

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

CROSS-REFERENCES TO RELATED APPLICATIONS

US Referenced Citations (215)

Foreign Referenced Citations (39)

Non-Patent Literature Citations (21)

Provisional Applications (1)

Continuation in Parts (5)

Number	Name	Date	Kind
2050904	Trice	Aug 1936	A
2056377	Wappler	Oct 1936	A
3815604	O'Malley et al.	Jun 1974	A
3828780	Morrison, Jr.	Aug 1974	A
3901242	Storz	Aug 1975	A
3920021	Hiltebrandt	Nov 1975	A
3939839	Curtiss	Feb 1976	A
3970088	Morrison	Jul 1976	A
4033351	Hetzel	Jul 1977	A
4040426	Morrison, Jr.	Aug 1977	A
4043342	Morrison, Jr.	Aug 1977	A
4074718	Morrison, Jr.	Feb 1978	A
4092986	Schneiderman	Jun 1978	A
4116198	Roos	Sep 1978	A
4181131	Ogiu	Jan 1980	A
4184492	Meinke et al.	Jan 1980	A
4202337	Hren et al.	May 1980	A
4228800	Degler, Jr. et al.	Oct 1980	A
4232676	Herczog	Nov 1980	A
4240441	Khalil	Dec 1980	A
4248231	Herczog et al.	Feb 1981	A
4326529	Doss et al.	Apr 1982	A
4381007	Doss	Apr 1983	A
4476862	Pao	Oct 1984	A
4532924	Auth et al.	Aug 1985	A
4548207	Reimels	Oct 1985	A
4567890	Ohta et al.	Feb 1986	A
4590934	Malis et al.	May 1986	A
4593691	Lindstrom et al.	Jun 1986	A
4660571	Hess et al.	Apr 1987	A
4674499	Pao	Jun 1987	A
4682596	Bales et al.	Jul 1987	A
4706667	Roos	Nov 1987	A
4709698	Johnston et al.	Dec 1987	A
4727874	Bowers et al.	Mar 1988	A
4765331	Petruzzi et al.	Aug 1988	A
4785807	Blanch	Nov 1988	A
4785823	Eggers et al.	Nov 1988	A
4805616	Pao	Feb 1989	A
4823791	D'Amelio et al.	Apr 1989	A
4832048	Cohen	May 1989	A
4860752	Turner	Aug 1989	A
4920978	Colvin	May 1990	A
4931047	Broadwin et al.	Jun 1990	A
4936281	Stasz	Jun 1990	A
4936301	Rexroth et al.	Jun 1990	A
4943290	Rexroth et al.	Jul 1990	A
4955377	Lennox et al.	Sep 1990	A
4966597	Cosman	Oct 1990	A
4967765	Turner et al.	Nov 1990	A
4976711	Parins et al.	Dec 1990	A
4979948	Geddes et al.	Dec 1990	A
4998933	Eggers et al.	Mar 1991	A
5007908	Rydell	Apr 1991	A
5009656	Reimels	Apr 1991	A
5035696	Rydell	Jul 1991	A
5047026	Rydell	Sep 1991	A
5047027	Rydell	Sep 1991	A
5057105	Malone et al.	Oct 1991	A
5057106	Kasevich et al.	Oct 1991	A
5078717	Parins et al.	Jan 1992	A
5080660	Buelna	Jan 1992	A
5083565	Parins	Jan 1992	A
5084044	Quint	Jan 1992	A
5085659	Rydell	Feb 1992	A
5088997	Delahuerga et al.	Feb 1992	A
5092339	Geddes et al.	Mar 1992	A
5098431	Rydell	Mar 1992	A
5099840	Goble et al.	Mar 1992	A
5100402	Fan	Mar 1992	A
5108391	Flachenecker et al.	Apr 1992	A
5112330	Nishigaki et al.	May 1992	A
5122138	Manwaring	Jun 1992	A
5125928	Parins et al.	Jun 1992	A
5167659	Ohtomo et al.	Dec 1992	A
5171311	Rydell et al.	Dec 1992	A
5178620	Eggers et al.	Jan 1993	A
5190517	Zieve et al.	Mar 1993	A
5190541	Abele et al.	Mar 1993	A
5192280	Parins	Mar 1993	A
5195959	Smith	Mar 1993	A
5197963	Parins	Mar 1993	A
5207675	Canady	May 1993	A
5217457	Delahuerga et al.	Jun 1993	A
5217459	Kamerling	Jun 1993	A
5217460	Knoepfler	Jun 1993	A
5249585	Turner et al.	Oct 1993	A
5261905	Doresey, III	Nov 1993	A
5267994	Gentelia et al.	Dec 1993	A
5267997	Farin et al.	Dec 1993	A
5273524	Fox et al.	Dec 1993	A
5277201	Stern	Jan 1994	A
5281216	Klicek	Jan 1994	A
5281218	Imran	Jan 1994	A
5282799	Rydell	Feb 1994	A
5290282	Casscells	Mar 1994	A
5300069	Hunsberger et al.	Apr 1994	A
5306238	Fleenor	Apr 1994	A
5312400	Bales et al.	May 1994	A
5314406	Arias et al.	May 1994	A
5318563	Malis et al.	Jun 1994	A
5324254	Phillips	Jun 1994	A
5330470	Hagen	Jul 1994	A
5334140	Phillips	Aug 1994	A
5334183	Wuchinich	Aug 1994	A
5336220	Ryan et al.	Aug 1994	A
5342357	Nardella	Aug 1994	A
5366443	Eggers et al.	Nov 1994	A
5370675	Edwards et al.	Dec 1994	A
5380277	Phillips	Jan 1995	A
5383876	Nardella	Jan 1995	A
5383917	Desai et al.	Jan 1995	A
5395312	Desai	Mar 1995	A
5417687	Nardella et al.	May 1995	A
5419767	Eggers et al.	May 1995	A
5423810	Goble et al.	Jun 1995	A
5423882	Jackman et al.	Jun 1995	A
5436566	Thompson et al.	Jul 1995	A
5438302	Goble	Aug 1995	A
5441499	Fritzsch	Aug 1995	A
5451224	Goble et al.	Sep 1995	A
5454809	Janssen	Oct 1995	A
5490850	Ellman et al.	Feb 1996	A
5496312	Klicek	Mar 1996	A
5514130	Baker	May 1996	A
5556397	Long et al.	Sep 1996	A
5562703	Desai	Oct 1996	A
5569242	Lax et al.	Oct 1996	A
5584872	LaFontaine et al.	Dec 1996	A
5609151	Mulier et al.	Mar 1997	A
5647869	Goble et al.	Jul 1997	A
5662680	Desai	Sep 1997	A
5676693	LaFontaine et al	Oct 1997	A
5681282	Eggers et al.	Oct 1997	A
5683366	Eggers et al.	Nov 1997	A
5697281	Eggers et al.	Dec 1997	A
5697536	Eggers et al.	Dec 1997	A
5697882	Eggers et al.	Dec 1997	A
5697909	Eggers et al.	Dec 1997	A
5700262	Acosta et al.	Dec 1997	A
5702390	Austin et al.	Dec 1997	A
5725524	Mulier et al.	Mar 1998	A
5749869	Lindenmeier et al.	May 1998	A
5766153	Eggers et al.	Jun 1998	A
5800431	Brown	Sep 1998	A
5807392	Eggers	Sep 1998	A
5807395	Mulier et al.	Sep 1998	A
5810764	Eggers et al.	Sep 1998	A
5810809	Rydell	Sep 1998	A
5843019	Eggers et al.	Dec 1998	A
5871469	Eggers et al.	Feb 1999	A
5873855	Eggers et al.	Feb 1999	A
5885277	Korth	Mar 1999	A
5888198	Eggers et al.	Mar 1999	A
5891095	Eggers et al.	Apr 1999	A
5893849	Weaver	Apr 1999	A
5897553	Mulier et al.	Apr 1999	A
5902272	Eggers et al.	May 1999	A
5944715	Goble et al.	Aug 1999	A
6004319	Goble et al.	Dec 1999	A
6013076	Goble et al.	Jan 2000	A
6015406	Goble et al.	Jan 2000	A
6024733	Eggers et al.	Feb 2000	A
6027501	Goble et al.	Feb 2000	A
6039734	Goble	Mar 2000	A
6056746	Goble et al.	May 2000	A
6063079	Hovda et al.	May 2000	A
6063083	Duong-Van	May 2000	A
6066134	Eggers et al.	May 2000	A
6066137	Greep	May 2000	A
6068628	Fanton et al.	May 2000	A
6074386	Goble et al.	Jun 2000	A
6090106	Goble et al.	Jul 2000	A
6093186	Goble et al.	Jul 2000	A
6096037	Mulier et al.	Aug 2000	A
6109268	Thapliyal et al.	Aug 2000	A
6117109	Eggers et al.	Sep 2000	A
6126682	Sharkey et al.	Oct 2000	A
6142992	Cheng et al.	Nov 2000	A
6149620	Baker et al.	Nov 2000	A
6159194	Eggers et al.	Dec 2000	A
6159208	Hovda et al.	Dec 2000	A
6168593	Sharkey et al.	Jan 2001	B1
6179824	Eggers et al.	Jan 2001	B1
6179836	Eggers et al.	Jan 2001	B1
6183469	Thapliyal et al.	Feb 2001	B1
6190381	Olsen et al.	Feb 2001	B1
6203542	Ellsberry et al.	Mar 2001	B1
6210402	Olsen et al.	Apr 2001	B1
6217575	DeVore et al.	Apr 2001	B1
6224592	Eggers et al.	May 2001	B1
6228081	Goble	May 2001	B1
6235020	Cheng et al.	May 2001	B1
6238391	Olsen et al.	May 2001	B1
6254600	Willink et al.	Jul 2001	B1
6261286	Goble et al.	Jul 2001	B1
6264652	Eggers et al.	Jul 2001	B1
6273887	Yamauchi et al.	Aug 2001	B1
6293942	Goble et al.	Sep 2001	B1
6296636	Cheng et al.	Oct 2001	B1
6296638	Davison et al.	Oct 2001	B1
6306134	Goble et al.	Oct 2001	B1
6312408	Eggers et al.	Nov 2001	B1
6322549	Eggers et al.	Nov 2001	B1
6355032	Hovda et al.	Mar 2002	B1
6363937	Hovda et al.	Apr 2002	B1
6379350	Sharkey et al.	Apr 2002	B1
6379351	Thapliyal et al.	Apr 2002	B1
6391025	Weinstein et al.	May 2002	B1
6416507	Eggers et al.	Jul 2002	B1
6416508	Eggers et al.	Jul 2002	B1
6432103	Ellsberry et al.	Aug 2002	B1
6468274	Alleyne et al.	Oct 2002	B1
6632193	Davison et al.	Oct 2003	B1
6632220	Eggers et al.	Oct 2003	B1

Entry
Pearce, John A. (1986) Electrosurgery, pp. 17, 67-75, 87, John Wiley & Sons, New York.
Costello, A. J. et al. “Nd:YAG Laser Ablation of the Prostate as a Treatment of Benign Prostatic Hypertrophy,” (1992) Lasers in Surger and Medicine 12:121-124.
J.W. Ramsey et al. Urological Research vol. 13, pp. 99-102 (1985).
V.E. Elsasser et al. Acta Medicotechnica vol. 24, No. 4, pp. 129-134 (1976).
P.C. Nardella (1989) SPIE 1068:42-49 Radio Frequency Energy and Impedance Feedback.
Rand et al. (1985) J. Arthro. Surg. 1:242-246 Effect of Electrocautery on Fresh Human Articular Cartilage.
Buchelt, M. et al. “Excimer Laser Ablation of Fibrocartilage: An In Vitro and In Vivo Study,” (1991) Lasers in Surgery and Medicine 11:271-279.
R. Tucker et al., Abstract P14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”.
R. Tucker et al. J. of Urology vol. 141, pp. 662-665, (1989).
R. Tucker et al. Urological Research vol. 18, pp. 291-294 (1990).
Kramolowsky et al. J. of Urology vol. 143, pp. 275-277 (1990).
Kramolowsky et al. J. of Urology vol. 146, pp. 669-674 (1991).
Slager et al. Z. Kardiol. 76:Suppl. 6, 67-71 (1987).
Slager et al. JACC 5(6):1382-6 (1985).
A.K. Dobbie Bio-Medical Engineering. vol. 4, pp. 206-216 (1969).
W. Honig IEEE pp. 58-65 (1975).
M.B. Dennis et al. Digestive Diseases and Sciences vol. 24(11), pp. 845-848 (1979).
K. Barry et al. American Heart Journal vol. 117, pp. 332-341 (1982).
C.P. Swain Gut vol. 25, pp. 1424-1431 (1984).
B. Lee et al. JACC vol. 13(5), pp. 1167-1175 (1989).
Piercey et al. Gastroenterology vol. 74(3), pp. 527-534 (1978).